<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops">
<head>
<meta http-equiv="default-style" content="text/html; charset=utf-8"/>
<title>Vascular and Interventional Imaging</title>
<link rel="stylesheet" type="text/css" href="../styles/Elsevier_eBook.css"/>
<link rel="stylesheet" type="text/css" href="../styles/media.css"/>
</head>
<body>
<section epub:type="chapter">
<section epub:type="subchapter">
<div class="boxg1" id="b0400"><a id="p6155" />
<div class="pageavoid" id="f0400"><figure class="fig"><img src="../images/F000027b02-79-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 93-1</span> <span class="figcredit">Courtesy of Dr. Daniel Brown.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0405"><figure class="fig"><img src="../images/F000027b02-80-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 93-2</span> <span class="figcredit">Courtesy of Dr. Daniel Brown.</span>
</figcaption>
</figure>
</div>
<section><a id="s1645" /><section><a id="s1650" /><section><a id="s1655" /><section><a id="s1660" />
<p class="b14hd" id="st1440">History</p>
<p id="p6160" class="b1textfl">A 42-year-old female presents with abdominal pain and hematuria.<a id="l1180" /></p>
<div><?mpslid S937?>
<p class="b1numlista" id="o4695"><a id="Case93-1" href="#Case093-1">1</a>.&#160;<a id="p6165" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1185" /></p><?mpslid S938?>
<p class="b1numlist1a" id="o4700">A.&#160;<a id="p6170" />Polyarteritis nodosa</p><?mpslid E938?><?mpslid S939?>
<p class="b1numlist1a" id="o4705">B.&#160;<a id="p6175" />Necrotizing angiitis secondary to methamphetamine use</p><?mpslid E939?><?mpslid S940?>
<p class="b1numlist1a" id="o4710">C.&#160;<a id="p6180" />Hepatic artery stenosis</p><?mpslid E940?><?mpslid S941?>
<p class="b1numlist1a" id="o4715">D.&#160;<a id="p6185" />Primary sclerosing cholangitis</p><?mpslid E941?><?mpslid E937?><?mpslid S942?>
<p class="b1numlista" id="o4720"><a id="Case93-2" href="#Case093-2">2</a>.&#160;<a id="p6190" />What aspects of these images allow for the identification of the disease process?<a id="l1190" /></p><?mpslid S943?>
<p class="b1numlist1a" id="o4725">A.&#160;<a id="p6195" />Evidence of multiple embolic phenomena</p><?mpslid E943?><?mpslid S944?>
<p class="b1numlist1a" id="o4730">B.&#160;<a id="p6200" />Diffuse involvement of the aorta</p><?mpslid E944?><?mpslid S945?>
<p class="b1numlist1a" id="o4735">C.&#160;<a id="p6205" />Multifocal stenoses and small aneurysms in the small and medium-size arteries</p><?mpslid E945?><?mpslid S946?>
<p class="b1numlist1a" id="o4740">D.&#160;<a id="p6210" />The tortuosity present in the large arterioles</p><?mpslid E946?><?mpslid E942?><?mpslid S947?>
<p class="b1numlista" id="o4745"><a id="Case93-3" href="#Case093-3">3</a>.&#160;<a id="p6215" />Which of the following arteries or territories is this process most likely to involve?<a id="l1195" /></p><?mpslid S948?>
<p class="b1numlist1a" id="o4750">A.&#160;<a id="p6220" />Hepatic arteries solely</p><?mpslid E948?><?mpslid S949?>
<p class="b1numlist1a" id="o4755">B.&#160;<a id="p6225" />Aorta and other large muscular arteries</p><?mpslid E949?><?mpslid S950?>
<p class="b1numlist1a" id="o4760">C.&#160;<a id="p6230" />Mesenteric arteries solely</p><?mpslid E950?><?mpslid S951?>
<p class="b1numlist1a" id="o4765">D.&#160;<a id="p6235" />Small and medium-sized muscular arteries</p><?mpslid E951?><?mpslid E947?><?mpslid S952?>
<p class="b1numlista" id="o4770"><a id="Case93-4" href="#Case093-4">4</a>.&#160;<a id="p6240" />What is the most effective treatment for this patient?<a id="l1200" /></p><?mpslid S953?>
<p class="b1numlist1a" id="o4775">A.&#160;<a id="p6245" />Conservative management with lifestyle modifications</p><?mpslid E953?><?mpslid S954?>
<p class="b1numlist1a" id="o4780">B.&#160;<a id="p6250" />Statin therapy and blood pressure control</p><?mpslid E954?><?mpslid S955?>
<p class="b1numlist1a" id="o4785">C.&#160;<a id="p6255" />Endovascular aneurysmal embolization</p><?mpslid E955?><?mpslid S956?>
<p class="b1numlist1a" id="o4790">D.&#160;<a id="p6260" />Combination of corticosteroids and immunosuppressive agents</p><?mpslid E956?><?mpslid E952?>
</div>
<p id="p6265" class="b1text">
<a epub:type="noteref" href="#fn0210" id="Cfn0210">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0210">
<a href="#Cfn0210"><sup>*</sup></a><a id="np0210" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0470tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P190" epub:type="pagebreak" title="190" />
<div class="boxg1" id="b0405">
<p class="b1title">Answers</p>
<p class="b1subt">Case 93</p>
<section><a id="s1665" />
<p class="b11hd" id="st1445">Polyarteritis Nodosa</p>
<a id="p6270" />
<a id="l1205" />
<div><?mpslid S957?>
<p class="b1numlista" id="o4795"><a id="Case093-1" href="#Case93-1">1</a>.&#160;<a id="p6275" /><strong>A and B.</strong> These two disease processes can present with identical angiographic findings found in this case. The diffuse stenotic and aneurysmal involvement of multiple small and medium-sized muscular arteries is classic for polyarteritis nodosa and necrotizing angiitis. Necrotizing angiitis is usually secondary to methamphetamine use, so a thorough history can help to differentiate the two. There are diffuse stenoses and aneurysms in these images that rule out hepatic artery stenosis and primary sclerosing cholangitis.</p><?mpslid E957?><?mpslid S958?>
<p class="b1numlista" id="o4800"><a id="Case093-2" href="#Case93-2">2</a>.&#160;<a id="p6280" /><strong>C.</strong> The presence of multifocal stenoses and aneurysms is classic for an angiographic diagnosis of polyarteritis nodosa. The aorta is not pictured in this image, there is no evidence of embolism, and the arteries do not show any evidence of increased tortuosity. The gold standard to diagnosis is biopsy of involved tissue.</p><?mpslid E958?><?mpslid S959?>
<p class="b1numlista" id="o4805"><a id="Case093-3" href="#Case93-3">3</a>.&#160;<a id="p6285" /><strong>D.</strong> Polyarteritis nodosa affects small and medium-sized vessels throughout the body. It mostly affects the renal arteries and hepatomesenteric arteries but can affect any small or medium-sized muscular arteries in the body. The disease spares the aorta and large muscular arteries.</p><?mpslid E959?><?mpslid S960?>
<p class="b1numlista" id="o4810"><a id="Case093-4" href="#Case93-4">4</a>.&#160;<a id="p6290" /><strong>D.</strong> The current treatment for polyarteritis nodosa is a combination of corticosteroids for acute episodes of the disease with immunosuppressive agents to prevent reemergence of symptoms. Statin therapy or conservative management would have no role in this situation. Other than hemorrhage from ruptured aneurysms, there are no endovascular interventions to treat polyarteritis nodosa.</p><?mpslid E960?>
</div>
<section><a id="s1670" />
<p class="b12hd" id="st1450">Comment</p>
<section><a id="s1675" />
<p class="b13hd" id="st1455">Imaging Interpretation</p>
<p id="p6295" class="b1textfl">The images demonstrate multifocal irregularity, stenoses, and small aneurysms in the small and medium-sized arteries of the hepatic circulation (<a href="chp004_a.xhtml#f1820">Figures S93-1</a> and <a href="chp004_a.xhtml#f1825">S93-2</a>). This appearance is most likely due to polyarteritis nodosa. Another condition that can produce an identical appearance is necrotizing angiitis due to drug abuse (often methamphetamines). When microaneurysms are present, the possibility of mycotic aneurysms must also be considered in the appropriate clinical context (e.g., fever and/or signs of sepsis), but the angiographic appearance shown here is much less likely to represent infection.</p>
</section>
<section><a id="s1680" />
<p class="b13hd" id="st1460">Disease Progression</p>
<p id="p6300" class="b1textfl">Polyarteritis nodosa is a systemic necrotizing vasculitis of small and medium-sized muscular arteries and arterioles. Patients can experience low-grade fever, myalgias and arthralgias, tender subcutaneous nodules, peripheral neuropathy, hematuria, and symptoms related to vascular involvement. The most commonly involved visceral vascular beds are the renal arteries (85%) and the hepatomesenteric circulation (50%). The large vessels, such as the aorta or major mesenteric trunks, are not likely to be involved.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0205" />
<h3 class="ref2hd" id="st1465">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0660">1. Hernandez-Rodriguez J, Alba MA, Prieto-Gonzalez S, et al. Diagnosis and classification of polyarteritis nodosa. <em>J Autoimmun</em>. 2014;48-49:84&#8211;89.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0665">2. Stanson AW, Friese JL, Johnson CM, et al. Polyarteritis nodosa: spectrum of angiographic findings. <em>Radiographics</em>. 2001;21:151&#8211;159.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0180" />
<h3 class="ref2hd" id="st1470">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0670">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 260.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0210" />
<span id="P191" epub:type="pagebreak" title="191" />
<h2 class="h1hd" id="sc0210tit">Case 94</h2>
<a id="p6305" />
<div class="boxg1" id="b0410"><a id="p6310" />
<div class="pageavoid" id="f0410"><figure class="fig"><img src="../images/F000027b02-81-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 94-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0415"><figure class="fig"><img src="../images/F000027b02-82-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 94-2</span></figcaption></figure></div>
<section><a id="s1685" /><section><a id="s1690" /><section><a id="s1695" /><section><a id="s1700" />
<p class="b14hd" id="st1475">History</p>
<p id="p6315" class="b1textfl">A 47-year-old female presents with persistent right upper quadrant pain, after cholecystostomy tube placement.<a id="l1210" /></p>
<div><?mpslid S961?>
<p class="b1numlista" id="o4815"><a id="Case94-1" href="#Case094-1">1</a>.&#160;<a id="p6320" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1215" /></p><?mpslid S962?>
<p class="b1numlist1a" id="o4820">A.&#160;<a id="p6325" />Cholangiocarcinoma</p><?mpslid E962?><?mpslid S963?>
<p class="b1numlist1a" id="o4825">B.&#160;<a id="p6330" />Cholelithiasis</p><?mpslid E963?><?mpslid S964?>
<p class="b1numlist1a" id="o4830">C.&#160;<a id="p6335" />Normal variant</p><?mpslid E964?><?mpslid S965?>
<p class="b1numlist1a" id="o4835">D.&#160;<a id="p6340" />Hepatocellular carcinoma</p><?mpslid E965?><?mpslid E961?><?mpslid S966?>
<p class="b1numlista" id="o4840"><a id="Case94-2" href="#Case094-2">2</a>.&#160;<a id="p6345" />What is the procedure of choice for cholelithiasis?<a id="l1220" /></p><?mpslid S967?>
<p class="b1numlist1a" id="o4845">A.&#160;<a id="p6350" />Percutaneous transhepatic cholangiogram and drainage</p><?mpslid E967?><?mpslid S968?>
<p class="b1numlist1a" id="o4850">B.&#160;<a id="p6355" />Choledochoscopy</p><?mpslid E968?><?mpslid S969?>
<p class="b1numlist1a" id="o4855">C.&#160;<a id="p6360" />Laparascopic cholecystectomy</p><?mpslid E969?><?mpslid S970?>
<p class="b1numlist1a" id="o4860">D.&#160;<a id="p6365" />Open cholecystectomy</p><?mpslid E970?><?mpslid E966?><?mpslid S971?>
<p class="b1numlista" id="o4865"><a id="Case94-3" href="#Case094-3">3</a>.&#160;<a id="p6370" />Which patients would optimally be treated by interventional radiology for cholelithiasis?<a id="l1225" /></p><?mpslid S972?>
<p class="b1numlist1a" id="o4870">A.&#160;<a id="p6375" />Young, otherwise healthy patients</p><?mpslid E972?><?mpslid S973?>
<p class="b1numlist1a" id="o4875">B.&#160;<a id="p6380" />Diabetics</p><?mpslid E973?><?mpslid S974?>
<p class="b1numlist1a" id="o4880">C.&#160;<a id="p6385" />Patients with acalculous cholecystitis</p><?mpslid E974?><?mpslid S975?>
<p class="b1numlist1a" id="o4885">D.&#160;<a id="p6390" />Elderly, debilitated patients</p><?mpslid E975?><?mpslid E971?><?mpslid S976?>
<p class="b1numlista" id="o4890"><a id="Case94-4" href="#Case094-4">4</a>.&#160;<a id="p6395" />Which of the following reasons might favor surgery over interventional radiology treatment for cholelithiasis?<a id="l1230" /></p><?mpslid S977?>
<p class="b1numlist1a" id="o4895">A.&#160;<a id="p6400" />Risk of recurrence</p><?mpslid E977?><?mpslid S978?>
<p class="b1numlist1a" id="o4900">B.&#160;<a id="p6405" />Risk of anesthetic complications</p><?mpslid E978?><?mpslid S979?>
<p class="b1numlist1a" id="o4905">C.&#160;<a id="p6410" />Poor rate of initial success</p><?mpslid E979?><?mpslid S980?>
<p class="b1numlist1a" id="o4910">D.&#160;<a id="p6415" />Longer hospital stay</p><?mpslid E980?><?mpslid E976?>
</div>
<p id="p6420" class="b1text">
<a epub:type="noteref" href="#fn0215" id="Cfn0215">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0215">
<a href="#Cfn0215"><sup>*</sup></a><a id="np0215" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0475tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P192" epub:type="pagebreak" title="192" />
<div class="boxg1" id="b0415">
<p class="b1title">Answers</p>
<p class="b1subt">Case 94</p>
<section><a id="s1705" />
<p class="b11hd" id="st1480">Percutaneous Gallstone Removal</p>
<a id="p6425" />
<a id="l1235" />
<div><?mpslid S981?>
<p class="b1numlista" id="o4915"><a id="Case094-1" href="#Case94-1">1</a>.&#160;<a id="p6430" /><strong>B.</strong> There are multiple filling defects in the gallbladder. There is no mass seen to suggest cholangiocarcinoma, which would be better evaluated with cross-sectional imaging. Hepatocellular carcinoma would not have this appearance and this is certainly not normal.</p><?mpslid E981?><?mpslid S982?>
<p class="b1numlista" id="o4920"><a id="Case094-2" href="#Case94-2">2</a>.&#160;<a id="p6435" /><strong>C.</strong> Laparoscopic cholecystectomy is the most definitive and efficient approach to permanent treatment and prevention of further episodes. Open cholecystectomy could be performed but is reserved for more complex cases. Choledochoscopy has a high rate of recurrence (up to 40 in 3 years) and drainage catheter placement will not solve the main problem of gallstones.</p><?mpslid E982?><?mpslid S983?>
<p class="b1numlista" id="o4925"><a id="Case094-3" href="#Case94-3">3</a>.&#160;<a id="p6440" /><strong>D.</strong> Percutaneous gallstone removal is usually reserved for patients who are unsuitable surgical candidates, usually elderly/debilitated patients who need symptomatic relief. Patients with acalculous cholecystitis may benefit from drainage without surgery. The other patients should receive laparoscopic cholecystectomy if possible.</p><?mpslid E983?><?mpslid S984?>
<p class="b1numlista" id="o4930"><a id="Case094-4" href="#Case94-4">4</a>.&#160;<a id="p6445" /><strong>A.</strong> Gallstone removal by interventional radiology can have up to 40% recurrence in 3 years because the gallstone-forming gallbladder remains in place. However, it is usually successful for stones up to 15&#160;mm and can involve a shorter hospital stay. Anesthetic complications may occur with either procedure.</p><?mpslid E984?>
</div>
<section><a id="s1710" />
<p class="b12hd" id="st1485">Comment</p>
<section><a id="s1715" />
<p class="b13hd" id="st1490">Main Teaching Point</p>
<p id="p6450" class="b1textfl">Patients with biliary stones and cholangitis are often managed with catheter drainage during the initial phase. Once the acute infection and inflammation have resolved, a decision needs to be made as to what the appropriate definitive management should be. In patients with cholelithiasis (gallstones), surgical resection is the definitive treatment. Imaging may be performed with ultrasonography, computed tomography, or magnetic resonance imaging.</p>
</section>
<section><a id="s1720" />
<p class="b13hd" id="st1495">Percutaneous Management</p>
<p id="p6455" class="b1textfl">Patients with significant contraindications for surgical resection are considered candidates for percutaneous methods of stone removal. After a mature transperitoneal tract has formed around the percutaneous drainage catheter (usually 2 to 4 weeks), the catheter is removed over a guidewire, the tract is dilated, and a large sheath is placed. Calculi are usually ultrasonically fragmented under endoscopic visualization, and the stone fragments are removed by aspiration and a variety of grasping devices (<a href="chp004_a.xhtml#f1830">Figures S94-1</a> through <a href="chp004_a.xhtml#f1840">S94-3</a>). Alternatively, the stones may be fragmented and pushed through the biliary tree into the gut. Following this, a drainage catheter is left in place. Once all stones are removed (as demonstrated by cholangiography), the cystic and common bile ducts are patent, and the patient is clinically well, the tube can be capped and subsequently removed.</p>
</section>
<section><a id="s1725" />
<p class="b13hd" id="st1500">Outcomes</p>
<p id="p6460" class="b1textfl">The recurrence rate of cholelithiasis following percutaneous removal is extremely high (perhaps 40% within 3 years). For this reason, this procedure is generally reserved for patients with significant surgical contraindications.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0210" />
<h3 class="ref2hd" id="st1505">Reference</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0675">1. Courtois CS, Picus D, Hicks ME. Percutaneous gallstone removal: long-term follow-up. <em>J Vasc Interv Radiol</em>. 1996;7:229&#8211;234.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0185" />
<h3 class="ref2hd" id="st1510">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0680">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 474&#8211;480.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0215" />
<span id="P193" epub:type="pagebreak" title="193" />
<h2 class="h1hd" id="sc0215tit">Case 95</h2>
<a id="p6465" />
<div class="boxg1" id="b0420"><a id="p6470" />
<div class="pageavoid" id="f0420"><figure class="fig"><img src="../images/F000027b02-83-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 95-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0425"><figure class="fig"><img src="../images/F000027b02-84-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 95-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s1730" /><section><a id="s1735" /><section><a id="s1740" /><section><a id="s1745" />
<p class="b14hd" id="st1515">History</p>
<p id="p6475" class="b1textfl">A 66-year-old male with recurrent gastrointestinal bleeding.<a id="l1240" /></p>
<div><?mpslid S985?>
<p class="b1numlista" id="o4935"><a id="Case95-1" href="#Case095-1">1</a>.&#160;<a id="p6480" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1245" /></p><?mpslid S986?>
<p class="b1numlist1a" id="o4940">A.&#160;<a id="p6485" />Gastritis</p><?mpslid E986?><?mpslid S987?>
<p class="b1numlist1a" id="o4945">B.&#160;<a id="p6490" />Gastric adenocarcinoma</p><?mpslid E987?><?mpslid S988?>
<p class="b1numlist1a" id="o4950">C.&#160;<a id="p6495" />Gastric varices</p><?mpslid E988?><?mpslid S989?>
<p class="b1numlist1a" id="o4955">D.&#160;<a id="p6500" />Gastrointestinal stromal tumor (GIST)</p><?mpslid E989?><?mpslid E985?><?mpslid S990?>
<p class="b1numlista" id="o4960"><a id="Case95-2" href="#Case095-2">2</a>.&#160;<a id="p6505" />Which procedure(s) would help treat this condition?<a id="l1250" /></p><?mpslid S991?>
<p class="b1numlist1a" id="o4965">A.&#160;<a id="p6510" />Transjugular intrahepatic portosystemic shunt (TIPS)</p><?mpslid E991?><?mpslid S992?>
<p class="b1numlist1a" id="o4970">B.&#160;<a id="p6515" />Balloon-occluded retrograde transvenous obliteration (BRTO)</p><?mpslid E992?><?mpslid S993?>
<p class="b1numlist1a" id="o4975">C.&#160;<a id="p6520" />Transarterial chemoembolization (TACE)</p><?mpslid E993?><?mpslid S994?>
<p class="b1numlist1a" id="o4980">D.&#160;<a id="p6525" />Radiofrequency ablation (RFA)</p><?mpslid E994?><?mpslid E990?><?mpslid S995?>
<p class="b1numlista" id="o4985"><a id="Case95-3" href="#Case095-3">3</a>.&#160;<a id="p6530" />In which condition would BRTO be preferred to TIPS?<a id="l1255" /></p><?mpslid S996?>
<p class="b1numlist1a" id="o4990">A.&#160;<a id="p6535" />Hepatic encephalopathy</p><?mpslid E996?><?mpslid S997?>
<p class="b1numlist1a" id="o4995">B.&#160;<a id="p6540" />Liver transplant candidate</p><?mpslid E997?><?mpslid S998?>
<p class="b1numlist1a" id="o5000">C.&#160;<a id="p6545" />Bleeding from GIST</p><?mpslid E998?><?mpslid S999?>
<p class="b1numlist1a" id="o5005">D.&#160;<a id="p6550" />Pancreatitis-induced pseudoaneurysm</p><?mpslid E999?><?mpslid E995?><?mpslid S1000?>
<p class="b1numlista" id="o5010"><a id="Case95-4" href="#Case095-4">4</a>.&#160;<a id="p6555" />What is a common complication after BRTO?<a id="l1260" /></p><?mpslid S1001?>
<p class="b1numlist1a" id="o5015">A.&#160;<a id="p6560" />Hepatic necrosis</p><?mpslid E1001?><?mpslid S1002?>
<p class="b1numlist1a" id="o5020">B.&#160;<a id="p6565" />Diaphragmatic injury</p><?mpslid E1002?><?mpslid S1003?>
<p class="b1numlist1a" id="o5025">C.&#160;<a id="p6570" />Hepatic encephalopathy</p><?mpslid E1003?><?mpslid S1004?>
<p class="b1numlist1a" id="o5030">D.&#160;<a id="p6575" />Esophageal variceal bleeding</p><?mpslid E1004?><?mpslid E1000?>
</div>
<p id="p6580" class="b1text">
<a epub:type="noteref" href="#fn0220" id="Cfn0220">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0220">
<a href="#Cfn0220"><sup>*</sup></a><a id="np0220" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0480tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P194" epub:type="pagebreak" title="194" />
<div class="boxg1" id="b0425">
<p class="b1title">Answers</p>
<p class="b1subt">Case 95</p>
<section><a id="s1750" />
<p class="b11hd" id="st1520">Balloon-Occluded Retrograde Tranvenous Obliteration of Gastric Varices</p>
<a id="p6585" />
<a id="l1265" />
<div><?mpslid S1005?>
<p class="b1numlista" id="o5035"><a id="Case095-1" href="#Case95-1">1</a>.&#160;<a id="p6590" /><strong>C.</strong> <a href="chp004_a.xhtml#f1845">Figures S95-1</a> and <a href="chp004_a.xhtml#f1850">S95-2</a> demonstrate opacificed, engorged vessels within the gastric wall, instead of gastric wall thickening. Adenocarcinoma and GIST are more mass-like; GISTs tend to be exophytic and adenocarcinoma often is not identified until late in the disease course.</p><?mpslid E1005?><?mpslid S1006?>
<p class="b1numlista" id="o5040"><a id="Case095-2" href="#Case95-2">2</a>.&#160;<a id="p6595" /><strong>A and B.</strong> TIPS and BRTO serve to decompress varices, albeit by differing methods. TACE and RFA are methods that interventional radiologists use to treat neoplasms.</p><?mpslid E1006?><?mpslid S1007?>
<p class="b1numlista" id="o5045"><a id="Case095-3" href="#Case95-3">3</a>.&#160;<a id="p6600" /><strong>A.</strong> Baseline hepatic encephalopathy is a relative contraindication to TIPS due to decreased filtration of blood products by the liver after an iatrogenically placed portosystemic shunt. GIST-related bleeding and pseudoaneurysms can be treated by direct embolization. Transplant candidates may receive BRTO as a temporizing measure, but it is not a first-line therapeutic procedure in these patients.</p><?mpslid E1007?><?mpslid S1008?>
<p class="b1numlista" id="o5050"><a id="Case095-4" href="#Case95-4">4</a>.&#160;<a id="p6605" /><strong>D.</strong> By shunting flow away from gastric varices, post-BRTO patients can bleed from other varices such as duodenal or esophageal varices up to 31% of the time. Hepatic necrosis may occur following TACE, diaphragmatic injury is a concern during RFA, and hepatic encephalopathy is a complication of TIPS.</p><?mpslid E1008?>
</div>
<section><a id="s1755" />
<p class="b12hd" id="st1525">Comment</p>
<section><a id="s1760" />
<p class="b13hd" id="st1530">Technical Concept</p>
<p id="p6610" class="b1textfl">Balloon-occluded transvenous obliteration of gastric varices was first described in 1984 by Olson, but it became a popular treatment in Japan. The concept behind the procedure is that in order to prevent gastric variceal bleeding, the varices must be sclerosed/obliterated. However, the challenge lies in prevention of sclerosant leakage into the systemic circulation. In order to prevent systemic sclerosant leakage, balloon-occlusion is performed by placing the balloon in the venous outflow tract proximal to the connection with systemic venous circulation. Subsequently, sclerosant is injected into the varices. Computed tomography is helpful in planning the BRTO procedure as well as in follow-up (<a href="chp004_a.xhtml#f1845">Figures S95-1</a>, <a href="chp004_a.xhtml#f1850">S95-2</a>, <a href="chp004_a.xhtml#f1865">S95-5</a>, and <a href="chp004_a.xhtml#f1870">S95-6</a>).</p>
</section>
<section><a id="s1765" />
<p class="b13hd" id="st1535">Procedural Technique</p>
<p id="p6615" class="b1textfl">BRTO generally takes place via a transjugular or transfemoral approach, with catheterization of the left renal vein and subsequent balloon-occlusion of the outflow of the gastric varices, which is at the left renal vein (<a href="chp004_a.xhtml#f1855">Figures S95-3</a> and <a href="chp004_a.xhtml#f1860">S95-4</a>). Techniques, such as those in the figures seen above, make use of Amplatzer plugs or coils instead of balloon-occlusion to prevent balloon rupture and reduce time of the procedure. Combination of BRTO with TIPS may have an even higher success rate, although more studies are forthcoming.</p>
</section>
<section><a id="s1770" />
<p class="b13hd" id="st1540">Outcomes/Complications</p>
<p id="p6620" class="b1textfl">There is a fairly high technical success rate of preventing gastric bleeding with BRTO (between 91% and 100% for patients after up to three treatments). However, the complication of subsequent secondary variceal bleeding from adjacent varices (esophageal, duodenal) due to increased shunting occurs in up to 31% of patients. Simultaneous treatment with TIPS may reduce this complication rate. However, the potential for hepatic encephalopathy with TIPS placement may serve as a contraindication to TIPS in certain patients.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0215" />
<h3 class="ref2hd" id="st1545">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0685">1. Saad W, Nicholson D. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques. <em>Tech Vasc Interv Radiol</em>. 2013;16:152&#8211;157.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0690">2. Saad W, Simon P, Rose S. Balloon-occluded retrograde transvenous obliteration of gastric varices. <em>Cardiovasc Intervent Radiol</em>. 2014;37:299&#8211;315.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0695">3. Saad W, Wagner C, Lippert A, et al. Protecting value of TIPS against the development of hydrothorax/ascites and upper gastrointestinal bleeding after balloon-occluded retrograde transvenous obliteration (BRTO). <em>Am J Gastroenterol</em>. 2013;108:1612&#8211;1619.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr9185" />
<h3 class="ref2hd" id="st9510">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb9515">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 325&#8211;326.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0220" />
<span id="P195" epub:type="pagebreak" title="195" />
<h2 class="h1hd" id="sc0220tit">Case 96</h2>
<a id="p6625" />
<div class="boxg1" id="b0430"><a id="p6630" />
<div class="pageavoid" id="f0430"><figure class="fig"><img src="../images/F000027b02-85-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 96-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0435"><figure class="fig"><img src="../images/F000027b02-86-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 96-2</span></figcaption></figure></div>
<section><a id="s1775" /><section><a id="s1780" /><section><a id="s1785" /><section><a id="s1790" />
<p class="b14hd" id="st1550">History</p>
<p id="p6635" class="b1textfl">A 46-year-old female presents with hematuria and shortness of breath.<a id="l1270" /></p>
<div><?mpslid S1009?>
<p class="b1numlista" id="o5055"><a id="Case96-1" href="#Case096-1">1</a>.&#160;<a id="p6640" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1275" /></p><?mpslid S1010?>
<p class="b1numlist1a" id="o5060">A.&#160;<a id="p6645" />Renal arteriovenous malformation (AVM)</p><?mpslid E1010?><?mpslid S1011?>
<p class="b1numlist1a" id="o5065">B.&#160;<a id="p6650" />Renal calculus</p><?mpslid E1011?><?mpslid S1012?>
<p class="b1numlist1a" id="o5070">C.&#160;<a id="p6655" />Normal</p><?mpslid E1012?><?mpslid S1013?>
<p class="b1numlist1a" id="o5075">D.&#160;<a id="p6660" />Renal angiomyolipoma (AML)</p><?mpslid E1013?><?mpslid E1009?><?mpslid S1014?>
<p class="b1numlista" id="o5080"><a id="Case96-2" href="#Case096-2">2</a>.&#160;<a id="p6665" />Which of the following is/are a potential sequela of the imaging findings?<a id="l1280" /></p><?mpslid S1015?>
<p class="b1numlist1a" id="o5085">A.&#160;<a id="p6670" />Congestive heart failure</p><?mpslid E1015?><?mpslid S1016?>
<p class="b1numlist1a" id="o5090">B.&#160;<a id="p6675" />Renal failure</p><?mpslid E1016?><?mpslid S1017?>
<p class="b1numlist1a" id="o5095">C.&#160;<a id="p6680" />Hypertension</p><?mpslid E1017?><?mpslid S1018?>
<p class="b1numlist1a" id="o5100">D.&#160;<a id="p6685" />All of the above</p><?mpslid E1018?><?mpslid E1014?><?mpslid S1019?>
<p class="b1numlista" id="o5105"><a id="Case96-3" href="#Case096-3">3</a>.&#160;<a id="p6690" />Which of the following renally-derived enzymes is involved in regulating blood pressure?<a id="l1285" /></p><?mpslid S1020?>
<p class="b1numlist1a" id="o5110">A.&#160;<a id="p6695" />Angiotensinogen</p><?mpslid E1020?><?mpslid S1021?>
<p class="b1numlist1a" id="o5115">B.&#160;<a id="p6700" />Renin</p><?mpslid E1021?><?mpslid S1022?>
<p class="b1numlist1a" id="o5120">C.&#160;<a id="p6705" />Angiotensin-converting enzyme (ACE)</p><?mpslid E1022?><?mpslid S1023?>
<p class="b1numlist1a" id="o5125">D.&#160;<a id="p6710" />Aldosterone</p><?mpslid E1023?><?mpslid E1019?><?mpslid S1024?>
<p class="b1numlista" id="o5130"><a id="Case96-4" href="#Case096-4">4</a>.&#160;<a id="p6715" />What are the recommended initial treatment options for this imaging finding?<a id="l1290" /></p><?mpslid S1025?>
<p class="b1numlist1a" id="o5135">A.&#160;<a id="p6720" />Radiofrequency ablation or cryoablation</p><?mpslid E1025?><?mpslid S1026?>
<p class="b1numlist1a" id="o5140">B.&#160;<a id="p6725" />Radical nephrectomy</p><?mpslid E1026?><?mpslid S1027?>
<p class="b1numlist1a" id="o5145">C.&#160;<a id="p6730" />Embolization</p><?mpslid E1027?><?mpslid S1028?>
<p class="b1numlist1a" id="o5150">D.&#160;<a id="p6735" />Lithotripsy</p><?mpslid E1028?><?mpslid E1024?>
</div>
<p id="p6740" class="b1text">
<a epub:type="noteref" href="#fn0225" id="Cfn0225">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0225">
<a href="#Cfn0225"><sup>*</sup></a><a id="np0225" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0485tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P196" epub:type="pagebreak" title="196" />
<div class="boxg1" id="b0435">
<p class="b1title">Answers</p>
<p class="b1subt">Case 96</p>
<section><a id="s1795" />
<p class="b11hd" id="st1555">Renal AVM</p>
<a id="p6745" />
<a id="l1295" />
<div><?mpslid S1029?>
<p class="b1numlista" id="o5155"><a id="Case096-1" href="#Case96-1">1</a>.&#160;<a id="p6750" /><strong>A.</strong> The images show an enlarged right renal artery with a large malformation and early venous filling. No mass lesion is seen to suggest AML. This is most certainly not a normal finding.</p><?mpslid E1029?><?mpslid S1030?>
<p class="b1numlista" id="o5160"><a id="Case096-2" href="#Case96-2">2</a>.&#160;<a id="p6755" /><strong>D.</strong> Congestive heart failure, hypertension, and hematuria are potential sequela of an AVM/fistula.</p><?mpslid E1030?><?mpslid S1031?>
<p class="b1numlista" id="o5165"><a id="Case096-3" href="#Case96-3">3</a>.&#160;<a id="p6760" /><strong>B.</strong> All of the mentioned enzymes are involved in the renin-angiotensin system. Renin is secreted by cells from the juxtaglomerular apparatus. It is cleaved by angiotensinogen, secreted from the liver, into angiotensinogen I. ACE in the lungs further cleaves angiotensinogen I to angiotensinogen II, which constricts blood vessels and activates the adrenal glands to release aldosterone.</p><?mpslid E1031?><?mpslid S1032?>
<p class="b1numlista" id="o5170"><a id="Case096-4" href="#Case96-4">4</a>.&#160;<a id="p6765" /><strong>C.</strong> Embolization is the first line recommended treatment option for renal AVMs/fistulas that are large and/or symptomatic (i.e., causing congestive heart failure, renal failure, hematuria). This lesion was large and the patient subsequently underwent coil embolization.</p><?mpslid E1032?>
</div>
<section><a id="s1800" />
<p class="b12hd" id="st1560">Comment</p>
<section><a id="s1805" />
<p class="b13hd" id="st1565">Etiology</p>
<p id="p6770" class="b1textfl">Renal AVMs are rare lesions that may be congenital or acquired. When they are acquired, the most common cause is iatrogenic injury secondary to a renal biopsy or other intervention. The lesions often manifest with recurrent gross hematuria, and they can even produce renovascular hypertension. Successful endovascular treatment of the abnormality generally results in regression of these symptoms.</p>
</section>
<section><a id="s1810" />
<p class="b13hd" id="st1570">Imaging Interpretation</p>
<p id="p6775" class="b1textfl">The selective right renal angiogram demonstrates opacification of a large AVM (<a href="chp004_a.xhtml#f1875">Figures S96-1</a> and <a href="chp004_a.xhtml#f1880">S96-2</a>). Early filling of the venous system is a characteristic finding of such lesions and emphasizes the importance of considering whether all opacified structures are appropriate for the particular phase of the angiogram being evaluated. Opacification of venous structures should never be apparent on arterial phase images.</p>
</section>
<section><a id="s1815" />
<p class="b13hd" id="st1575">Endovascular Management</p>
<p id="p6780" class="b1textfl">Endovascular therapy for simple renal AVMs (like the one pictured here) usually consists of embolization with a coil or vascular plug of the feeding artery (<a href="chp004_a.xhtml#f1885">Figures S96-3</a> and <a href="chp004_a.xhtml#f1890">S96-4</a>). If the lesion is more complex, then particle embolization may be used to treat the abnormality while preserving the kidney for as long as possible; however, such lesions often recur following embolization, and total or partial nephrectomy is likely to be needed eventually.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0220" />
<h3 class="ref2hd" id="st1580">Reference</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0700">1. Dinkel HP, Danauser H, Triller J. Blunt renal trauma: minimally invasive management with microcatheter embolization experience in nine patients. <em>Radiology</em>. 2002;223:723&#8211;730.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0190" />
<h3 class="ref2hd" id="st1585">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0705">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 284.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0225" />
<span id="P197" epub:type="pagebreak" title="197" />
<h2 class="h1hd" id="sc0225tit">Case 97</h2>
<a id="p6785" />
<div class="boxg1" id="b0440"><a id="p6790" />
<div class="pageavoid" id="f0440"><figure class="fig"><img src="../images/F000027b02-87-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 97-1</span> <span class="figcredit">Courtesy of Dr. David M. Williams.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0445"><figure class="fig"><img src="../images/F000027b02-88-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 97-2</span> <span class="figcredit">Courtesy of Dr. David M. Williams.</span>
</figcaption>
</figure>
</div>
<section><a id="s1820" /><section><a id="s1825" /><section><a id="s1830" /><section><a id="s1835" />
<p class="b14hd" id="st1590">History</p>
<p id="p6795" class="b1textfl">A 21-year-old female with history of oral contraceptive use and obesity presents with low back pain and bilateral leg swelling.<a id="l1300" /></p>
<div><?mpslid S1033?>
<p class="b1numlista" id="o5175"><a id="Case97-1" href="#Case097-1">1</a>.&#160;<a id="p6800" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1305" /></p><?mpslid S1034?>
<p class="b1numlist1a" id="o5180">A.&#160;<a id="p6805" />Lymphadenopathy</p><?mpslid E1034?><?mpslid S1035?>
<p class="b1numlist1a" id="o5185">B.&#160;<a id="p6810" />Retroperitoneal sarcoma</p><?mpslid E1035?><?mpslid S1036?>
<p class="b1numlist1a" id="o5190">C.&#160;<a id="p6815" />Aortic aneurysm</p><?mpslid E1036?><?mpslid S1037?>
<p class="b1numlist1a" id="o5195">D.&#160;<a id="p6820" />Inferior vena cava (IVC) thrombosis</p><?mpslid E1037?><?mpslid E1033?><?mpslid S1038?>
<p class="b1numlista" id="o5200"><a id="Case97-2" href="#Case097-2">2</a>.&#160;<a id="p6825" />What is the most common etiology of the findings demonstrated in the images above?<a id="l1310" /></p><?mpslid S1039?>
<p class="b1numlist1a" id="o5205">A.&#160;<a id="p6830" />Metastatic disease</p><?mpslid E1039?><?mpslid S1040?>
<p class="b1numlist1a" id="o5210">B.&#160;<a id="p6835" />Primary neoplasm</p><?mpslid E1040?><?mpslid S1041?>
<p class="b1numlist1a" id="o5215">C.&#160;<a id="p6840" />Presence of IVC filter</p><?mpslid E1041?><?mpslid S1042?>
<p class="b1numlist1a" id="o5220">D.&#160;<a id="p6845" />Atherosclerosis</p><?mpslid E1042?><?mpslid E1038?><?mpslid S1043?>
<p class="b1numlista" id="o5225"><a id="Case97-3" href="#Case097-3">3</a>.&#160;<a id="p6850" />What is the preferred treatment of this condition?<a id="l1315" /></p><?mpslid S1044?>
<p class="b1numlist1a" id="o5230">A.&#160;<a id="p6855" />Recanalization</p><?mpslid E1044?><?mpslid S1045?>
<p class="b1numlist1a" id="o5235">B.&#160;<a id="p6860" />IVC filter placement</p><?mpslid E1045?><?mpslid S1046?>
<p class="b1numlist1a" id="o5240">C.&#160;<a id="p6865" />Surgical resection</p><?mpslid E1046?><?mpslid S1047?>
<p class="b1numlist1a" id="o5245">D.&#160;<a id="p6870" />Medical management</p><?mpslid E1047?><?mpslid E1043?><?mpslid S1048?>
<p class="b1numlista" id="o5250"><a id="Case97-4" href="#Case097-4">4</a>.&#160;<a id="p6875" />What additional factors must be considered?<a id="l1320" /></p><?mpslid S1049?>
<p class="b1numlist1a" id="o5255">A.&#160;<a id="p6880" />Aortic diameter</p><?mpslid E1049?><?mpslid S1050?>
<p class="b1numlist1a" id="o5260">B.&#160;<a id="p6885" />Metastatic disease</p><?mpslid E1050?><?mpslid S1051?>
<p class="b1numlist1a" id="o5265">C.&#160;<a id="p6890" />Venous inflow</p><?mpslid E1051?><?mpslid S1052?>
<p class="b1numlist1a" id="o5270">D.&#160;<a id="p6895" />Pulmonary reserve</p><?mpslid E1052?><?mpslid E1048?>
</div>
<p id="p6900" class="b1text">
<a epub:type="noteref" href="#fn0230" id="Cfn0230">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0230">
<a href="#Cfn0230"><sup>*</sup></a><a id="np0230" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0490tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P198" epub:type="pagebreak" title="198" />
<div class="boxg1" id="b0445">
<p class="b1title">Answers</p>
<p class="b1subt">Case 97</p>
<section><a id="s1840" />
<p class="b11hd" id="st1595">IVC Thrombosis</p>
<a id="p6905" />
<a id="l1325" />
<div><?mpslid S1053?>
<p class="b1numlista" id="o5275"><a id="Case097-1" href="#Case97-1">1</a>.&#160;<a id="p6910" /><strong>D.</strong> There is no mass present and the aorta is of normal caliber. The images demonstrate filling defect within the IVC.</p><?mpslid E1053?><?mpslid S1054?>
<p class="b1numlista" id="o5280"><a id="Case097-2" href="#Case97-2">2</a>.&#160;<a id="p6915" /><strong>C.</strong> IVC filters, especially those that have been in place for a prolonged period of time, increase the risk of thrombosis of the IVC, especially in hypercoagulable patients. Atherosclerosis does not typically affect the venous system and no mass is seen.</p><?mpslid E1054?><?mpslid S1055?>
<p class="b1numlista" id="o5285"><a id="Case097-3" href="#Case97-3">3</a>.&#160;<a id="p6920" /><strong>A.</strong> Recanalization of the IVC with stent placement is the preferred treatment in appropriately selected patients (see below). IVC filters can be placed during the perioperative period, but should not remain in place for a prolonged period of time. Medical management with anticoagulation should be instituted, but should not be the only treatment. Surgical resection would not treat the underlying condition.</p><?mpslid E1055?><?mpslid S1056?>
<p class="b1numlista" id="o5290"><a id="Case097-4" href="#Case97-4">4</a>.&#160;<a id="p6925" /><strong>C.</strong> Venous inflow to the IVC must be patent in order to maintain patency of the recanalized IVC. The remaining choices are simply red herrings, although pulmonary reserve may be a consideration in some patients, requiring general anesthesia for the intervention.</p><?mpslid E1056?>
</div>
<section><a id="s1845" />
<p class="b12hd" id="st1600">Comment</p>
<section><a id="s1850" />
<p class="b13hd" id="st1605">Main Teaching Point</p>
<p id="p6930" class="b1textfl">Depending upon collateral formation and the extent of venous involvement, the symptoms of IVC thrombosis can include bilateral lower-extremity and lower-body wall edema and lower-extremity pain. Anticoagulation therapy is typically given to minimize the acute symptomatology and to decrease the substantial risk of pulmonary embolism. In carefully selected patients, catheter-directed thrombolysis can be used to achieve venous recanalization as well. Computed tomography or magnetic resonance venography are commonly employed for diagnosis (<a href="chp004_a.xhtml#f1895">Figures S97-1</a> and <a href="chp004_a.xhtml#f1900">S97-2</a>).</p>
</section>
<section><a id="s1855" />
<p class="b13hd" id="st1610">Etiology</p>
<p id="p6935" class="b1textfl">The etiologies of IVC thrombosis include IVC filter placement, abdominal malignancy with mass effect upon the IVC, sepsis, dehydration, and hypercoagulability. Abdominal tumors can cause IVC thrombosis via compression or outright invasion. The most common histology of such lesions is renal cell carcinoma, although other lesions such as hepatocellular carcinoma, adrenal carcinoma, nodal metastases, and IVC leiomyoma/leiomyosarcomas can cause IVC thrombosis as well. In patients with renal cell carcinoma, the presence of IVC involvement does not usually preclude surgical resection.</p>
</section>
<section><a id="s1860" />
<p class="b13hd" id="st1615">Endovascular Management</p>
<p id="p6940" class="b1textfl">Certain considerations must be undertaken prior to IVC recanalization. First, the patient must be in a state of health in which she would benefit from recanalization and able to tolerate anticoagulation. The venous inflow must be interrogated and appropriately treated because inflow patency is required to maintain integrity of recanalized IVC. Placement of IVC filters above the occlusion prior to recanalization should be considered. Once access is obtained across the occlusion, balloon angioplasty and stenting are performed as necessary (<a href="chp004_a.xhtml#f1905">Figures S97-3</a> and <a href="chp004_a.xhtml#f1910">S97-4</a>). Primary patency is between 38% and 40%, and secondary patency rates are around 79% to 86% at 54 months. Follow-up is generally performed with ultrasound or CTV although these modalities are quite technique-dependent. Repeat venography is the most accurate way to assess for in-stent stenosis with the added benefit of the ability to biopsy any filling defects.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0225" />
<h3 class="ref2hd" id="st1620">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0710">1. Bjarnason H. Tips and tricks for stenting the inferior vena cava. <em>Semin Vasc Surg</em>. 2013;26:29&#8211;34.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0715">2. Razavi MK, Hansch EC, Kee ST, et al. Chronically occluded inferior venae cavae: endovascular treatment. <em>Radiology</em>. 2000;214:133&#8211;138.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0720">3. Williams DM. Iliocaval reconstruction in chronic deep vein thrombosis. <em>Tech Vasc Interv Radiol</em>. 2014;17:109&#8211;113.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0195" />
<h3 class="ref2hd" id="st1625">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0725">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 293&#8211;301.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0230" />
<span id="P199" epub:type="pagebreak" title="199" />
<h2 class="h1hd" id="sc0230tit">Case 98</h2>
<a id="p6945" />
<div class="boxg1" id="b0450"><a id="p6950" />
<div class="pageavoid" id="f0450"><figure class="fig"><img src="../images/F000027b02-89-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 98-1</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0455"><figure class="fig"><img src="../images/F000027b02-90-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 98-2</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<section><a id="s1865" /><section><a id="s1870" /><section><a id="s1875" /><section><a id="s1880" />
<p class="b14hd" id="st1630">History</p>
<p id="p6955" class="b1textfl">A 47-year-old male presents with pelvic fullness. The patient recently had a lymph node dissection.<a id="l1330" /></p>
<div><?mpslid S1057?>
<p class="b1numlista" id="o5295"><a id="Case98-1" href="#Case098-1">1</a>.&#160;<a id="p6960" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1335" /></p><?mpslid S1058?>
<p class="b1numlist1a" id="o5300">A.&#160;<a id="p6965" />Hematoma</p><?mpslid E1058?><?mpslid S1059?>
<p class="b1numlist1a" id="o5305">B.&#160;<a id="p6970" />Seroma</p><?mpslid E1059?><?mpslid S1060?>
<p class="b1numlist1a" id="o5310">C.&#160;<a id="p6975" />Abscess</p><?mpslid E1060?><?mpslid S1061?>
<p class="b1numlist1a" id="o5315">D.&#160;<a id="p6980" />Lymphocele</p><?mpslid E1061?><?mpslid E1057?><?mpslid S1062?>
<p class="b1numlista" id="o5320"><a id="Case98-2" href="#Case098-2">2</a>.&#160;<a id="p6985" />A drain was placed into the collection and the fluid was sent for analysis. What are the expected fluid characteristics for a pelvic lymphocele?<a id="l1340" /></p><?mpslid S1063?>
<p class="b1numlist1a" id="o5325">A.&#160;<a id="p6990" />Sterile fluid with few lymphocytes</p><?mpslid E1063?><?mpslid S1064?>
<p class="b1numlist1a" id="o5330">B.&#160;<a id="p6995" />Sterile fluid with many lymphocytes</p><?mpslid E1064?><?mpslid S1065?>
<p class="b1numlist1a" id="o5335">C.&#160;<a id="p7000" />Gram-negative rods with few lymphocytes</p><?mpslid E1065?><?mpslid S1066?>
<p class="b1numlist1a" id="o5340">D.&#160;<a id="p7005" />Gram-negative rods with many lymphocytes</p><?mpslid E1066?><?mpslid E1062?><?mpslid S1067?>
<p class="b1numlista" id="o5345"><a id="Case98-3" href="#Case098-3">3</a>.&#160;<a id="p7010" />What is the most common cause of a pelvic lymphocele?<a id="l1345" /></p><?mpslid S1068?>
<p class="b1numlist1a" id="o5350">A.&#160;<a id="p7015" />Spontaneous</p><?mpslid E1068?><?mpslid S1069?>
<p class="b1numlist1a" id="o5355">B.&#160;<a id="p7020" />Following pelvic lymph node dissection</p><?mpslid E1069?><?mpslid S1070?>
<p class="b1numlist1a" id="o5360">C.&#160;<a id="p7025" />Following hip arthroplasty</p><?mpslid E1070?><?mpslid S1071?>
<p class="b1numlist1a" id="o5365">D.&#160;<a id="p7030" />Following colonoscopy</p><?mpslid E1071?><?mpslid E1067?><?mpslid S1072?>
<p class="b1numlista" id="o5370"><a id="Case98-4" href="#Case098-4">4</a>.&#160;<a id="p7035" />Prior to performing ethanol sclerosis for a lymphocele, which of the following should be excluded? (Choose all that apply.)<a id="l1350" /></p><?mpslid S1073?>
<p class="b1numlist1a" id="o5375">A.&#160;<a id="p7040" />Persistent drainage from the lymphocele</p><?mpslid E1073?><?mpslid S1074?>
<p class="b1numlist1a" id="o5380">B.&#160;<a id="p7045" />Colonic fistula</p><?mpslid E1074?><?mpslid S1075?>
<p class="b1numlist1a" id="o5385">C.&#160;<a id="p7050" />Sterile fluid collection</p><?mpslid E1075?><?mpslid S1076?>
<p class="b1numlist1a" id="o5390">D.&#160;<a id="p7055" />Infected fluid collection</p><?mpslid E1076?><?mpslid E1072?>
</div>
<p id="p7060" class="b1text">
<a epub:type="noteref" href="#fn0235" id="Cfn0235">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0235">
<a href="#Cfn0235"><sup>*</sup></a><a id="np0235" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0495tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P200" epub:type="pagebreak" title="200" />
<div class="boxg1" id="b0455">
<p class="b1title">Answers</p>
<p class="b1subt">Case 98</p>
<section><a id="s1885" />
<p class="b11hd" id="st1635">Pelvic Lymphocele</p>
<a id="p7065" />
<a id="l1355" />
<div><?mpslid S1077?>
<p class="b1numlista" id="o5395"><a id="Case098-1" href="#Case98-1">1</a>.&#160;<a id="p7070" /><strong>A, B, C, and D.</strong> In the setting of recent pelvic lymph node dissection, all four answer choices should be included in the differential. Analysis of the drained fluid can narrow the differential.</p><?mpslid E1077?><?mpslid S1078?>
<p class="b1numlista" id="o5400"><a id="Case098-2" href="#Case98-2">2</a>.&#160;<a id="p7075" /><strong>B.</strong> Fluid from a lymphocele is characteristically sterile with an extremely high lymphocyte concentration.</p><?mpslid E1078?><?mpslid S1079?>
<p class="b1numlista" id="o5405"><a id="Case098-3" href="#Case98-3">3</a>.&#160;<a id="p7080" /><strong>B.</strong> Pelvic lymphoceles most commonly occur following pelvic lymph node dissection. It is thought that transection of afferent lymphatic vessels during lymph node dissection causes lymphatic fluid to accumulate. Other operations with transection of lymphatic vessels may also result in a lymphocele. Spontaneous lymphoceles are rare.</p><?mpslid E1079?><?mpslid S1080?>
<p class="b1numlista" id="o5410"><a id="Case098-4" href="#Case98-4">4</a>.&#160;<a id="p7085" /><strong>B and D.</strong> Prior to performing ethanol sclerosis for a pelvic lymphocele, a fistula should be excluded. This can be done by injecting contrast into the fluid collection. Additionally, the diagnosis should be confirmed by fluid analysis prior to ethanol sclerosis. The fluid from a lymphocele is typically sterile with many lymphocytes. If the fluid is not sterile, an abscess must be considered and ethanol sclerosis should not be performed.</p><?mpslid E1080?>
</div>
<section><a id="s1890" />
<p class="b12hd" id="st1640">Comment</p>
<section><a id="s1895" />
<p class="b13hd" id="st1645">Main Teaching Point</p>
<p id="p7090" class="b1textfl">The images demonstrate the typical appearance of a postoperative pelvic lymphocele (<a href="chp004_a.xhtml#f1915">Figures S98-1</a> and <a href="chp004_a.xhtml#f1920">S98-2</a>). If the patient is symptomatic (commonly pain, fever, or leg swelling due to iliac vein compression), the intervention of first choice is percutaneous aspiration with possible drainage. The aspirated fluid should be sent for laboratory analysis as described, because the differential diagnosis is broad. If the collection is sterile and has an extremely high concentration of lymphocytes, the diagnosis of lymphocele is made.</p>
</section>
<section><a id="s1900" />
<p class="b13hd" id="st1650">Percutaneous Management</p>
<p id="p7095" class="b1textfl">Although catheter drainage is sometimes successful as stand-alone therapy, a significant percentage of lymphoceles do not completely resolve with catheter drainage alone because lymphatic channels within the wall of the collection continue to produce fluid. In this situation, if the collection is not infected and no fistula is present, then periodic (usually 2 to 3 times per week) instillation of absolute ethanol or another sclerosant can produce cessation of fluid output from the collection, eventually allowing removal of the catheter (<a href="chp004_a.xhtml#f1925">Figures S98-3</a> and <a href="chp004_a.xhtml#f1930">S98-4</a>). In general, at least several sessions of sclerosis are needed, and the entire process can take up to several months in a minority of cases.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0230" />
<h3 class="ref2hd" id="st1655">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0730">1. Kim JK, Jeong YY, Kim YH, et al. Postoperative pelvic lymphocele: treatment with simple percutaneous catheter drainage. <em>Radiology</em>. 1999;212:390&#8211;394.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0735">2. Zuckerman DA, Yeager TD. Percutaneous ethanol sclerotherapy of postoperative lymphoceles. <em>Am J Roentgenol</em>. 1997;169:433&#8211;437.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0200" />
<h3 class="ref2hd" id="st1660">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0740">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 416.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0235" />
<span id="P201" epub:type="pagebreak" title="201" />
<h2 class="h1hd" id="sc0235tit">Case 99</h2>
<a id="p7100" />
<div class="boxg1" id="b0460"><a id="p7105" />
<div class="pageavoid" id="f0460"><figure class="fig"><img src="../images/F000027b02-91-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 99-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0465"><figure class="fig"><img src="../images/F000027b02-92-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 99-2</span></figcaption></figure></div>
<section><a id="s1905" /><section><a id="s1910" /><section><a id="s1915" /><section><a id="s1920" />
<p class="b14hd" id="st1665">History</p>
<p id="p7110" class="b1textfl">A 54-year-old male with a history of hyperlipidemia and smoking presents with worsening bilateral calf claudication. He was found to have palpable pulsatile masses within the bilateral popliteal fossa on physical exam.<a id="l1360" /></p>
<div><?mpslid S1081?>
<p class="b1numlista" id="o5415"><a id="Case99-1" href="#Case099-1">1</a>.&#160;<a id="p7115" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1365" /></p><?mpslid S1082?>
<p class="b1numlist1a" id="o5420">A.&#160;<a id="p7120" />Popliteal artery rupture</p><?mpslid E1082?><?mpslid S1083?>
<p class="b1numlist1a" id="o5425">B.&#160;<a id="p7125" />Popliteal artery aneurysm</p><?mpslid E1083?><?mpslid S1084?>
<p class="b1numlist1a" id="o5430">C.&#160;<a id="p7130" />Popliteal artery entrapment</p><?mpslid E1084?><?mpslid S1085?>
<p class="b1numlist1a" id="o5435">D.&#160;<a id="p7135" />Cystic adventitial disease of the popliteal artery</p><?mpslid E1085?><?mpslid E1081?><?mpslid S1086?>
<p class="b1numlista" id="o5440"><a id="Case99-2" href="#Case099-2">2</a>.&#160;<a id="p7140" />What is the most common complication of the imaging findings presented?<a id="l1370" /></p><?mpslid S1087?>
<p class="b1numlist1a" id="o5445">A.&#160;<a id="p7145" />Rupture</p><?mpslid E1087?><?mpslid S1088?>
<p class="b1numlist1a" id="o5450">B.&#160;<a id="p7150" />Infection</p><?mpslid E1088?><?mpslid S1089?>
<p class="b1numlist1a" id="o5455">C.&#160;<a id="p7155" />Paralysis</p><?mpslid E1089?><?mpslid S1090?>
<p class="b1numlist1a" id="o5460">D.&#160;<a id="p7160" />Thrombosis</p><?mpslid E1090?><?mpslid E1086?><?mpslid S1091?>
<p class="b1numlista" id="o5465"><a id="Case99-3" href="#Case099-3">3</a>.&#160;<a id="p7165" />This patient should be screened for a similar disease process in which vascular territory?<a id="l1375" /></p><?mpslid S1092?>
<p class="b1numlist1a" id="o5470">A.&#160;<a id="p7170" />Brachial</p><?mpslid E1092?><?mpslid S1093?>
<p class="b1numlist1a" id="o5475">B.&#160;<a id="p7175" />Renal</p><?mpslid E1093?><?mpslid S1094?>
<p class="b1numlist1a" id="o5480">C.&#160;<a id="p7180" />Aorta</p><?mpslid E1094?><?mpslid S1095?>
<p class="b1numlist1a" id="o5485">D.&#160;<a id="p7185" />Anterior communicating artery</p><?mpslid E1095?><?mpslid E1091?><?mpslid S1096?>
<p class="b1numlista" id="o5490"><a id="Case99-4" href="#Case099-4">4</a>.&#160;<a id="p7190" />What is a potential treatment option for this disease?<a id="l1380" /></p><?mpslid S1097?>
<p class="b1numlist1a" id="o5495">A.&#160;<a id="p7195" />Thrombin injection</p><?mpslid E1097?><?mpslid S1098?>
<p class="b1numlist1a" id="o5500">B.&#160;<a id="p7200" />Compression</p><?mpslid E1098?><?mpslid S1099?>
<p class="b1numlist1a" id="o5505">C.&#160;<a id="p7205" />Distal bypass</p><?mpslid E1099?><?mpslid S1100?>
<p class="b1numlist1a" id="o5510">D.&#160;<a id="p7210" />Embolization</p><?mpslid E1100?><?mpslid E1096?>
</div>
<p id="p7215" class="b1text">
<a epub:type="noteref" href="#fn0240" id="Cfn0240">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0240">
<a href="#Cfn0240"><sup>*</sup></a><a id="np0240" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0500tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P202" epub:type="pagebreak" title="202" />
<div class="boxg1" id="b0465">
<p class="b1title">Answers</p>
<p class="b1subt">Case 99</p>
<section><a id="s1925" />
<p class="b11hd" id="st1670">Popliteal Artery Aneurysm</p>
<a id="p7220" />
<a id="l1385" />
<div><?mpslid S1101?>
<p class="b1numlista" id="o5515"><a id="Case099-1" href="#Case99-1">1</a>.&#160;<a id="p7225" /><strong>B.</strong> The computed tomography (CT) and angiographic images demonstrate bilateral popliteal artery aneurysms. There is no extravasation of contrast to suggest rupture.</p><?mpslid E1101?><?mpslid S1102?>
<p class="b1numlista" id="o5520"><a id="Case099-2" href="#Case99-2">2</a>.&#160;<a id="p7230" /><strong>D.</strong> Acute popliteal aneurysm thrombosis resulting in acute limb ischemia occurs in up to 40% of patients who are followed conservatively. Alternatively, the thrombus formed within the popliteal aneurysm may shower distal emboli.</p><?mpslid E1102?><?mpslid S1103?>
<p class="b1numlista" id="o5525"><a id="Case099-3" href="#Case99-3">3</a>.&#160;<a id="p7235" /><strong>C.</strong> Approximately 37% of patients with popliteal artery aneurysms will have an abdominal aortic aneurysm.</p><?mpslid E1103?><?mpslid S1104?>
<p class="b1numlista" id="o5530"><a id="Case099-4" href="#Case99-4">4</a>.&#160;<a id="p7240" /><strong>C.</strong> Current therapeutic interventions for popliteal artery aneurysms include surgical bypass and endovascular stent placement.</p><?mpslid E1104?>
</div>
<section><a id="s1930" />
<p class="b12hd" id="st1675">Comment</p>
<section><a id="s1935" />
<p class="b13hd" id="st1680">Main Teaching Point</p>
<p id="p7245" class="b1textfl">Popliteal artery aneurysms are commonly bilateral (50%), and they often coexist with aneurysms in another location, most commonly abdominal aortic aneurysms and common femoral artery aneurysms. The most common presenting symptoms include lower-extremity ischemia and compression of adjacent nerves or other structures. Although rupture of popliteal aneurysms can occur, this complication is quite uncommon (&#60;&#160;5% of patients). More commonly, popliteal aneurysms manifest with limb-threatening ischemia due to distal embolization (20%) or popliteal artery thrombosis (40%). The risk factors for popliteal aneurysm thrombosis have been found to include poor distal runoff, presence of thrombus, and diameter greater than or equal to 2&#160;cm. However, even small aneurysms can produce limb-threatening ischemia. Imaging evaluation may include CT, magnetic resonance imaging, ultrasonography, or catheter-based angiography (<a href="chp004_a.xhtml#f1935">Figures S99-1</a> through <a href="chp004_a.xhtml#f1945">S99-3</a>).</p>
</section>
<section><a id="s1940" />
<p class="b13hd" id="st1685">Treatment Methods</p>
<p id="p7250" class="b1textfl">The accepted standard treatment approach for popliteal artery aneurysms is surgical aneurysm resection with distal bypass. Endovascular stent-grafting is generally of the best benefit in patients with high perioperative risk for surgery. Endovascular stent placement in patients with popliteal artery aneurysms who are not at high perioperative surgical risk is controversial and is a subject of ongoing debate. Recent literature has demonstrated that endovascular repair is associated with an increased risk of reintervention and graft thrombosis within 30 days compared to open surgery but no significant difference in primary and secondary patency rates in the long-term (12 and 72 months). Currently it is recommended that endovascular repair of popliteal artery aneurysms be considered on a case-by-case basis (<a href="chp004_a.xhtml#f1950">Figures S99-4</a> and <a href="chp004_a.xhtml#f1955">S99-5</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0235" />
<h3 class="ref2hd" id="st1690">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0745">1. Antonello M, Frigatti P, Battocchio P, et al. Endovascular treatment of asymptomatic popliteal aneurysms: 8-year concurrent comparison with open repair. <em>J Cardiovasc Surg (Torino)</em>. 2007;48:267&#8211;274.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0750">2. Joshi D, James RL, Jones L. Endovascular versus open repair of asymptomatic popliteal artery aneurysm. <em>Cochrane Database Syst Rev</em>. 2014;8:CD010149.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0755">3. Piazza M, Menegolo M, Ferrari A, et al. Long-term outcomes and sac volume shrinkage after endovascular popliteal artery aneurysm repair. <em>Eur J Vasc Endovasc Surg</em>. 2014;48:161&#8211;168.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0205" />
<h3 class="ref2hd" id="st1695">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0760">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 354&#8211;357.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0240" />
<span id="P203" epub:type="pagebreak" title="203" />
<h2 class="h1hd" id="sc0240tit">Case 100</h2>
<a id="p7255" />
<div class="boxg1" id="b0470"><a id="p7260" />
<div class="pageavoid" id="f0470"><figure class="fig"><img src="../images/F000027b02-93-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 100-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0475"><figure class="fig"><img src="../images/F000027b02-94-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 100-2</span></figcaption></figure></div>
<section><a id="s1945" /><section><a id="s1950" /><section><a id="s1955" /><section><a id="s1960" />
<p class="b14hd" id="st1700">History</p>
<p id="p7265" class="b1textfl">A 55-year-old male presents with right upper quadrant pain, emesis, and diarrhea.<a id="l1390" /></p>
<div><?mpslid S1105?>
<p class="b1numlista" id="o5535"><a id="Case100-1" href="#Case0100-1">1</a>.&#160;<a id="p7270" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1395" /></p><?mpslid S1106?>
<p class="b1numlist1a" id="o5540">A.&#160;<a id="p7275" />Portal vein thrombosis</p><?mpslid E1106?><?mpslid S1107?>
<p class="b1numlist1a" id="o5545">B.&#160;<a id="p7280" />Gallbladder carcinoma</p><?mpslid E1107?><?mpslid S1108?>
<p class="b1numlist1a" id="o5550">C.&#160;<a id="p7285" />Gallbladder rupture</p><?mpslid E1108?><?mpslid S1109?>
<p class="b1numlist1a" id="o5555">D.&#160;<a id="p7290" />Adenomyomatosis</p><?mpslid E1109?><?mpslid E1105?><?mpslid S1110?>
<p class="b1numlista" id="o5560"><a id="Case100-2" href="#Case0100-2">2</a>.&#160;<a id="p7295" />The most common route of percutaneous cholecystostomy is transhepatic. Which of the following is <em>NOT</em> a theoretical advantage of transhepatic cholecystostomy?<a id="l1400" /></p><?mpslid S1111?>
<p class="b1numlist1a" id="o5565">A.&#160;<a id="p7300" />Decreased risk of bile leak</p><?mpslid E1111?><?mpslid S1112?>
<p class="b1numlist1a" id="o5570">B.&#160;<a id="p7305" />Decreased risk of colonic injury</p><?mpslid E1112?><?mpslid S1113?>
<p class="b1numlist1a" id="o5575">C.&#160;<a id="p7310" />Decreased risk of pneumothorax</p><?mpslid E1113?><?mpslid S1114?>
<p class="b1numlist1a" id="o5580">D.&#160;<a id="p7315" />More rapid fibrin sheath formation, facilitating subsequent removal</p><?mpslid E1114?><?mpslid E1110?><?mpslid S1115?>
<p class="b1numlista" id="o5585"><a id="Case100-3" href="#Case0100-3">3</a>.&#160;<a id="p7320" />Which type of gallbladder rupture is depicted in this case?<a id="l1405" /></p><?mpslid S1116?>
<p class="b1numlist1a" id="o5590">A.&#160;<a id="p7325" />Type I</p><?mpslid E1116?><?mpslid S1117?>
<p class="b1numlist1a" id="o5595">B.&#160;<a id="p7330" />Type II</p><?mpslid E1117?><?mpslid S1118?>
<p class="b1numlist1a" id="o5600">C.&#160;<a id="p7335" />Type III</p><?mpslid E1118?><?mpslid S1119?>
<p class="b1numlist1a" id="o5605">D.&#160;<a id="p7340" />Type IV</p><?mpslid E1119?><?mpslid E1115?><?mpslid S1120?>
<p class="b1numlista" id="o5610"><a id="Case100-4" href="#Case0100-4">4</a>.&#160;<a id="p7345" />Five days following the initiation of intravenous antibiotics and percutaneous cholecystostomy, the patient remains febrile, tachycardic, and hypotensive. On physical exam, the patient has persistent right upper quadrant tenderness without rebound or guarding. What is the most likely diagnosis?<a id="l1410" /></p><?mpslid S1121?>
<p class="b1numlist1a" id="o5615">A.&#160;<a id="p7350" />Portal vein thrombosis</p><?mpslid E1121?><?mpslid S1122?>
<p class="b1numlist1a" id="o5620">B.&#160;<a id="p7355" />Pericholecystic abscess</p><?mpslid E1122?><?mpslid S1123?>
<p class="b1numlist1a" id="o5625">C.&#160;<a id="p7360" />Acute hepatitis</p><?mpslid E1123?><?mpslid S1124?>
<p class="b1numlist1a" id="o5630">D.&#160;<a id="p7365" />Bile peritonitis</p><?mpslid E1124?><?mpslid E1120?>
</div>
<p id="p7370" class="b1text">
<a epub:type="noteref" href="#fn0245" id="Cfn0245">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0245">
<a href="#Cfn0245"><sup>*</sup></a><a id="np0245" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0505tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P204" epub:type="pagebreak" title="204" />
<div class="boxg1" id="b0475">
<p class="b1title">Answers</p>
<p class="b1subt">Case 100</p>
<section><a id="s1965" />
<p class="b11hd" id="st1705">Gallbladder Rupture with Pericholecystic Abscess</p>
<a id="p7375" />
<a id="l1415" />
<div><?mpslid S1125?>
<p class="b1numlista" id="o5635"><a id="Case0100-1" href="#Case100-1">1</a>.&#160;<a id="p7380" /><strong>C.</strong> The computed tomography images demonstrates diffuse gallbladder wall thickening, pericholecystic fluid, and increased enhancement of the liver surrounding the gallbladder fossa. These findings are consistent with acute cholecystitis. However, there is also a focal defect within the fundus of the gallbladder that is concerning for gallbladder rupture.</p><?mpslid E1125?><?mpslid S1126?>
<p class="b1numlista" id="o5640"><a id="Case0100-2" href="#Case100-2">2</a>.&#160;<a id="p7385" /><strong>C.</strong> In most cases, there is no difference in the risk of pneumothorax from a transhepatic technique versus a transperitoneal approach. The transhepatic cholecystostomy technique has the advantage of a decreased risk of bile leak, decreased risk of colonic injury, and more rapid fibrin sheath formation, which facilitates subsequent removal.</p><?mpslid E1126?><?mpslid S1127?>
<p class="b1numlista" id="o5645"><a id="Case0100-3" href="#Case100-3">3</a>.&#160;<a id="p7390" /><strong>B.</strong> The image depicts a type II gallbladder perforation, localized gallbladder rupture with a pericholecystic abscess. A type I gallbladder perforation is where there is rupture of the gallbladder into the peritoneum with generalized peritonitis. A type III perforation occurs when there is a cholecystoenteric fistula. There is no type IV perforation.</p><?mpslid E1127?><?mpslid S1128?>
<p class="b1numlista" id="o5650"><a id="Case0100-4" href="#Case100-4">4</a>.&#160;<a id="p7395" /><strong>B.</strong> The initial image demonstrates a pericholecystic abscess in addition to gallbladder perforation. In these cases, the abscess must also be drained in addition to the gallbladder. This can be performed by placing additional side holes in the cholecystostomy catheter or by placing a separate abscess drain. The absence of rebound and guarding on physical exam make bile peritonitis unlikely.</p><?mpslid E1128?>
</div>
<section><a id="s1970" />
<p class="b12hd" id="st1710">Comment</p>
<section><a id="s1975" />
<p class="b13hd" id="st1715">Main Teaching Point</p>
<p id="p7400" class="b1textfl">Complications of acute cholecystitis can include free rupture into the peritoneum or contained rupture with pericholecystic abscess formation (<a href="chp004_a.xhtml#f1960">Figures S100-1</a> and <a href="chp004_a.xhtml#f1965">S100-2</a>). Historically, the presence of gallbladder rupture was an absolute indication for emergency cholecystectomy. In modern practice, however, most surgeons much prefer to operate after the acute infection and pericholecystic inflammation have subsided. For these reasons, percutaneous cholecystostomy may still be performed. However, the abscess must also be drained, either using the same drainage catheter with additional side-holes created to drain the abscess or via a separate (second) catheter (<a href="chp004_a.xhtml#f1970">Figure S100-3</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0240" />
<h3 class="ref2hd" id="st1720">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0765">1. Ahkan O, Akinsi D, Ozmen MN. Percutaneous cholecystostomy. <em>Eur J Radiol</em>. 2002;43:229&#8211;236.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0770">2. Sato K. Percutaneous management of biliary emergencies. <em>Semin Intervent Rad</em>. 2006;23:249&#8211;257.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0210" />
<h3 class="ref2hd" id="st1725">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0775">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 474&#8211;480.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0245" />
<span id="P205" epub:type="pagebreak" title="205" />
<h2 class="h1hd" id="sc0245tit">Case 101</h2>
<a id="p7405" />
<div class="boxg1" id="b0480"><a id="p7410" />
<div class="pageavoid" id="f0480"><figure class="fig"><img src="../images/F000027b02-95a-9781455776306.jpg" class="img" alt="image" />
<img src="../images/F000027b02-95b-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 101-1</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0485"><figure class="fig"><img src="../images/F000027b02-96-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 101-2</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<section><a id="s1980" /><section><a id="s1985" /><section><a id="s1990" /><section><a id="s1995" />
<p class="b14hd" id="st1730">History</p>
<p id="p7415" class="b1textfl">A 60-year-old male with history of uncontrolled hypertension and bilateral lower-extremity edema.<a id="l1420" /></p>
<div><?mpslid S1129?>
<p class="b1numlista" id="o5655"><a id="Case101-1" href="#Case0101-1">1</a>.&#160;<a id="p7420" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1425" /></p><?mpslid S1130?>
<p class="b1numlist1a" id="o5660">A.&#160;<a id="p7425" />Aortic stenosis</p><?mpslid E1130?><?mpslid S1131?>
<p class="b1numlist1a" id="o5665">B.&#160;<a id="p7430" />Abdominal aortic aneurysm</p><?mpslid E1131?><?mpslid S1132?>
<p class="b1numlist1a" id="o5670">C.&#160;<a id="p7435" />Aortic dissection</p><?mpslid E1132?><?mpslid S1133?>
<p class="b1numlist1a" id="o5675">D.&#160;<a id="p7440" />Penetrating ulcers within the abdominal aorta</p><?mpslid E1133?><?mpslid E1129?><?mpslid S1134?>
<p class="b1numlista" id="o5680"><a id="Case101-2" href="#Case0101-2">2</a>.&#160;<a id="p7445" />The hypointense material adherent to the aortic wall seen on these images most likely represents:<a id="l1430" /></p><?mpslid S1135?>
<p class="b1numlist1a" id="o5685">A.&#160;<a id="p7450" />Intramural hematoma</p><?mpslid E1135?><?mpslid S1136?>
<p class="b1numlist1a" id="o5690">B.&#160;<a id="p7455" />Fibrofatty atheromatous plaque</p><?mpslid E1136?><?mpslid S1137?>
<p class="b1numlist1a" id="o5695">C.&#160;<a id="p7460" />Calcified atheromatous plaque</p><?mpslid E1137?><?mpslid S1138?>
<p class="b1numlist1a" id="o5700">D.&#160;<a id="p7465" />Mycotic aneurysm</p><?mpslid E1138?><?mpslid E1134?><?mpslid S1139?>
<p class="b1numlista" id="o5705"><a id="Case101-3" href="#Case0101-3">3</a>.&#160;<a id="p7470" />The most appropriate treatment for aortic stenosis secondary to focal, concentric, short lesions is:<a id="l1435" /></p><?mpslid S1140?>
<p class="b1numlist1a" id="o5710">A.&#160;<a id="p7475" />Percutaneous balloon angioplasty</p><?mpslid E1140?><?mpslid S1141?>
<p class="b1numlist1a" id="o5715">B.&#160;<a id="p7480" />Aortofemoral bypass graft</p><?mpslid E1141?><?mpslid S1142?>
<p class="b1numlist1a" id="o5720">C.&#160;<a id="p7485" />Endarterectomy</p><?mpslid E1142?><?mpslid S1143?>
<p class="b1numlist1a" id="o5725">D.&#160;<a id="p7490" />Percutaneous balloon angioplasty followed by stent placement</p><?mpslid E1143?><?mpslid E1139?><?mpslid S1144?>
<p class="b1numlista" id="o5730"><a id="Case101-4" href="#Case0101-4">4</a>.&#160;<a id="p7495" />Stent placement may be least helpful after percutaneous balloon angioplasty for treatment of aortic stenosis in which of the following circumstances?<a id="l1440" /></p><?mpslid S1145?>
<p class="b1numlist1a" id="o5735">A.&#160;<a id="p7500" />Flow-limiting dissection occurs after angioplasty.</p><?mpslid E1145?><?mpslid S1146?>
<p class="b1numlist1a" id="o5740">B.&#160;<a id="p7505" />The stenosis recurs following successful angioplasty.</p><?mpslid E1146?><?mpslid S1147?>
<p class="b1numlist1a" id="o5745">C.&#160;<a id="p7510" />No pressure gradient is present across the lesion after angioplasty.</p><?mpslid E1147?><?mpslid S1148?>
<p class="b1numlist1a" id="o5750">D.&#160;<a id="p7515" />Angioplasty fails to reduce the stenosis to less than 30% diameter.</p><?mpslid E1148?><?mpslid E1144?>
</div>
<p id="p7520" class="b1text">
<a epub:type="noteref" href="#fn0250" id="Cfn0250">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0250">
<a href="#Cfn0250"><sup>*</sup></a><a id="np0250" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0510tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P206" epub:type="pagebreak" title="206" />
<div class="boxg1" id="b0485">
<p class="b1title">Answers</p>
<p class="b1subt">Case 101</p>
<section><a id="s2000" />
<p class="b11hd" id="st1735">Abdominal Aortic Stenosis</p>
<a id="p7525" />
<a id="l1445" />
<div><?mpslid S1149?>
<p class="b1numlista" id="o5755"><a id="Case0101-1" href="#Case101-1">1</a>.&#160;<a id="p7530" /><strong>A.</strong> Contrast-enhanced magnetic resonance (MR) angiography shows severe stenosis of the suprarenal abdominal aorta with occlusion of the proximal celiac, superior, and inferior mesenteric arteries. No aortic aneurysm, penetrating ulcers, or intimal flap from aortic dissection are seen.</p><?mpslid E1149?><?mpslid S1150?>
<p class="b1numlista" id="o5760"><a id="Case0101-2" href="#Case101-2">2</a>.&#160;<a id="p7535" /><strong>C.</strong> Calcium appears hypointense on all types of MR sequences, whereas it appears hyperdense on computed tomography (CT). Although MR is less sensitive than CT to detect small calcifications, the marked hypointensity seen on these images highly suggests the extensive calcium component of the atheromatous plaques.</p><?mpslid E1150?><?mpslid S1151?>
<p class="b1numlista" id="o5765"><a id="Case0101-3" href="#Case101-3">3</a>.&#160;<a id="p7540" /><strong>A.</strong> Although aortofemoral bypass grafting is associated with high patency rates, percutaneous interventions are usually used first for appropriate lesions because of their lower morbidity rates. For focal, concentric, short lesions, percutaneous balloon angioplasty is an appropriate first treatment.</p><?mpslid E1151?><?mpslid S1152?>
<p class="b1numlista" id="o5770"><a id="Case0101-4" href="#Case101-4">4</a>.&#160;<a id="p7545" /><strong>C.</strong> Postangioplasty stent placement may be performed if flow-limiting dissection occurs following angioplasty, if angioplasty fails to reduce the stenosis to less than 30% diameter, if a persistent pressure gradient (&#62;&#160;10&#160;mm&#160;Hg systolic) is present across the lesion after angioplasty, or if the stenosis recurs following successful angioplasty.</p><?mpslid E1152?>
</div>
<section><a id="s2005" />
<p class="b12hd" id="st1740">Comment</p>
<section><a id="s2010" />
<p class="b13hd" id="st1745">Clinical Presentation</p>
<p id="p7550" class="b1textfl">Although hypertension, diabetes, and hyperlipidemia are all associated with the development of atherosclerotic lesions, patients with a history of smoking are particularly prone to develop occlusive disease in the aorta and iliac arteries as seen in this patient (<a href="chp004_a.xhtml#f1975">Figures S101-1</a> and <a href="chp004_a.xhtml#f1980">S101-2</a>).</p>
</section>
<section><a id="s2015" />
<p class="b13hd" id="st1750">Management Options</p>
<p id="p7555" class="b1textfl">Invasive therapy is only performed in patients with lifestyle-limiting claudication or rest pain. Although aortofemoral bypass grafting is associated with high patency rates, percutaneous interventions are usually used first for appropriate lesions because of their lower morbidity rates. For focal, concentric, short lesions, percutaneous balloon angioplasty is an appropriate first treatment. Patencies following aortic angioplasty are comparable to those associated with iliac artery lesions. Endarterectomy, the surgical removal of the plaque, is usually performed when there is involvement of the visceral arteries, as in the case we present (<a href="chp004_a.xhtml#f1985">Figure S101-3</a>).</p>
</section>
<section><a id="s2020" />
<p class="b13hd" id="st1755">Indications for Stent Placement</p>
<p id="p7560" class="b1textfl">Postangioplasty stent placement may be performed if flow-limiting dissection occurs following angioplasty, if angioplasty fails to reduce the stenosis to less than 30% diameter, if a persistent pressure gradient (&#62;&#160;10&#160;mm&#160;Hg systolic) is present across the lesion after angioplasty, or if the stenosis recurs following successful angioplasty. Primary stent placement (placement of a stent without preceding angioplasty) is generally used for extremely calcified or eccentric lesions.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0245" />
<h3 class="ref2hd" id="st1760">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0780">1. Sandhu C, Belli AM. Abdominal aortic stenting: current practice. <em>Abdom Imaging</em>. 2001;6:453&#8211;460.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0785">2. Shih MC1, Angle JF, Leung DA, et al. CTA and MRA in mesenteric ischemia: part 2, normal findings and complications after surgical and endovascular treatment. <em>Am J Roentgenol</em>. 2007;188:462&#8211;471.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0215" />
<h3 class="ref2hd" id="st1765">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0790">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 209&#8211;214.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0250" />
<span id="P207" epub:type="pagebreak" title="207" />
<h2 class="h1hd" id="sc0250tit">Case 102</h2>
<a id="p7565" />
<div class="boxg1" id="b0490"><a id="p7570" />
<div class="pageavoid" id="f0490"><figure class="fig"><img src="../images/F000027b02-97-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 102-1</span> <span class="figcredit">Courtesy of Dr. Peter Liu.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0495"><figure class="fig"><img src="../images/F000027b02-98-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 102-2</span> <span class="figcredit">Courtesy of Dr. Peter Liu.</span>
</figcaption>
</figure>
</div>
<section><a id="s2025" /><section><a id="s2030" /><section><a id="s2035" /><section><a id="s2040" />
<p class="b14hd" id="st1770">History</p>
<p id="p7575" class="b1textfl">A 35-year-old male presents to the emergency department with chest pain radiating to his back.<a id="l1450" /></p>
<div><?mpslid S1153?>
<p class="b1numlista" id="o5775"><a id="Case102-1" href="#Case0102-1">1</a>.&#160;<a id="p7580" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1455" /></p><?mpslid S1154?>
<p class="b1numlist1a" id="o5780">A.&#160;<a id="p7585" />Aortic dissection</p><?mpslid E1154?><?mpslid S1155?>
<p class="b1numlist1a" id="o5785">B.&#160;<a id="p7590" />Double aortic arch</p><?mpslid E1155?><?mpslid S1156?>
<p class="b1numlist1a" id="o5790">C.&#160;<a id="p7595" />Mural thrombus</p><?mpslid E1156?><?mpslid S1157?>
<p class="b1numlist1a" id="o5795">D.&#160;<a id="p7600" />Penetrating atherosclerotic ulcer</p><?mpslid E1157?><?mpslid E1153?><?mpslid S1158?>
<p class="b1numlista" id="o5800"><a id="Case102-2" href="#Case0102-2">2</a>.&#160;<a id="p7605" />What other modalities are commonly used for diagnostic confirmation? (Choose all that apply.)<a id="l1460" /></p><?mpslid S1159?>
<p class="b1numlist1a" id="o5805">A.&#160;<a id="p7610" />Chest radiography</p><?mpslid E1159?><?mpslid S1160?>
<p class="b1numlist1a" id="o5810">B.&#160;<a id="p7615" />Computed tomography (CT) angiography</p><?mpslid E1160?><?mpslid S1161?>
<p class="b1numlist1a" id="o5815">C.&#160;<a id="p7620" />Transesophageal echocardiography (TEE)</p><?mpslid E1161?><?mpslid S1162?>
<p class="b1numlist1a" id="o5820">D.&#160;<a id="p7625" />Transthoracic echocardiography</p><?mpslid E1162?><?mpslid E1158?><?mpslid S1163?>
<p class="b1numlista" id="o5825"><a id="Case102-3" href="#Case0102-3">3</a>.&#160;<a id="p7630" />What is one of the major complications of this given entity?<a id="l1465" /></p><?mpslid S1164?>
<p class="b1numlist1a" id="o5830">A.&#160;<a id="p7635" />Compression of the adjacent structures</p><?mpslid E1164?><?mpslid S1165?>
<p class="b1numlist1a" id="o5835">B.&#160;<a id="p7640" />Saccular aneurysm formation</p><?mpslid E1165?><?mpslid S1166?>
<p class="b1numlist1a" id="o5840">C.&#160;<a id="p7645" />Abdominal organ malperfusion</p><?mpslid E1166?><?mpslid S1167?>
<p class="b1numlist1a" id="o5845">D.&#160;<a id="p7650" />Septic embolism</p><?mpslid E1167?><?mpslid E1163?><?mpslid S1168?>
<p class="b1numlista" id="o5850"><a id="Case102-4" href="#Case0102-4">4</a>.&#160;<a id="p7655" />Which one of the following syndromes may predispose the patient to developing this entity?<a id="l1470" /></p><?mpslid S1169?>
<p class="b1numlist1a" id="o5855">A.&#160;<a id="p7660" />Marfan syndrome</p><?mpslid E1169?><?mpslid S1170?>
<p class="b1numlist1a" id="o5860">B.&#160;<a id="p7665" />Tuberous sclerosis</p><?mpslid E1170?><?mpslid S1171?>
<p class="b1numlist1a" id="o5865">C.&#160;<a id="p7670" />Neurofibromatosis type I</p><?mpslid E1171?><?mpslid S1172?>
<p class="b1numlist1a" id="o5870">D.&#160;<a id="p7675" />Sturge-Weber syndrome</p><?mpslid E1172?><?mpslid E1168?>
</div>
<p id="p7680" class="b1text">
<a epub:type="noteref" href="#fn0255" id="Cfn0255">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0255">
<a href="#Cfn0255"><sup>*</sup></a><a id="np0255" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0515tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P208" epub:type="pagebreak" title="208" />
<div class="boxg1" id="b0495">
<p class="b1title">Answers</p>
<p class="b1subt">Case 102</p>
<section><a id="s2045" />
<p class="b11hd" id="st1775">Magnetic Resonance Imaging of Aortic Dissection</p>
<a id="p7685" />
<a id="l1475" />
<div><?mpslid S1173?>
<p class="b1numlista" id="o5875"><a id="Case0102-1" href="#Case102-1">1</a>.&#160;<a id="p7690" /><strong>A.</strong> The images demonstrate a dissection flap in the visualized thoracoabdominal aorta. The flap did not extend into the ascending aorta (not pictured), making this a type B aortic dissection. Penetrating atherosclerotic ulcer would show a focal, contrast, or blood-filled outpouching/crater. A mural thrombus would not be subintimal and would not show flow-related enhancement in the false lumen, as seen here.</p><?mpslid E1173?><?mpslid S1174?>
<p class="b1numlista" id="o5880"><a id="Case0102-2" href="#Case102-2">2</a>.&#160;<a id="p7695" /><strong>B and C.</strong> Multiple research studies have shown an equally reliable diagnostic value of all of these three modalities for the diagnosis of aortic dissection. In fact, TEE is commonly employed during open aortic repair for aortic dissection.</p><?mpslid E1174?><?mpslid S1175?>
<p class="b1numlista" id="o5885"><a id="Case0102-3" href="#Case102-3">3</a>.&#160;<a id="p7700" /><strong>C.</strong> Extension of the dissection into the visceral vessels is a well-known complication of aortic dissection. Septic embolism or compression of adjacent structures is not as well reported in the literature as dissection-related complications. Saccular aortic aneurysm is rare and can be seen with trauma or penetrating aortic ulcer. Dissections may lead to fusiform aneurysmal formation.</p><?mpslid E1175?><?mpslid S1176?>
<p class="b1numlista" id="o5890"><a id="Case0102-4" href="#Case102-4">4</a>.&#160;<a id="p7705" /><strong>A.</strong> Patients with Marfan syndrome are predisposed to have connective tissue abnormalities, which make them more likely to develop aortic dissection. The other listed syndromes do not have a known increased incidence of aortic dissection.</p><?mpslid E1176?>
</div>
<section><a id="s2050" />
<p class="b12hd" id="st1780">Comment</p>
<section><a id="s2055" />
<p class="b13hd" id="st1785">Diagnostic Imaging</p>
<p id="p7710" class="b1textfl">Magnetic resonance imaging (MRI) is equal or superior to helical CT and TEE for making the diagnosis of acute and chronic aortic dissection (<a href="chp004_a.xhtml#f1990">Figures S102-1</a> through <a href="chp004_a.xhtml#f2005">S102-4</a>). The longer image-acquisition time and greater difficulty in patient monitoring in the MRI scanner have been considered relative disadvantages of its use in the acute aortic dissection setting. However, MRI and helical CT are better able than TEE to evaluate the entire aorta (including its subdiaphragmatic segment), and MRI has the advantage in not requiring iodinated contrast. In current practice, aortography is reserved for evaluating patients with clinical evidence of complications of aortic dissection for whom surgical or interventional therapy is being planned.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0250" />
<h3 class="ref2hd" id="st1790">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0795">1. Criado FJ. Aortic dissection: a 250-year perspective. <em>Tex Heart Inst J</em>. 2011;38:694&#8211;700.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0800">2. Macura KJ, Corl FM, Fishman EK, et al. Pathogenesis in acute aortic syndromes: aortic dissection, intramural hematoma, and penetrating atherosclerotic ulcer. <em>Am J Roentgenol</em>. 2003;181:309&#8211;316.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0805">3. Shiga T, Wajima Z, Apfel CC, et al. Diagnostic accuracy of transesophageal echocardiography, helical computed tomography, and magnetic resonance imaging for suspected thoracic aortic dissection: systemic review and meta-analysis. <em>Arch Intern Med</em>. 2006;166:1350&#8211;1356.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0220" />
<h3 class="ref2hd" id="st1795">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0810">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 188&#8211;192.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0255" />
<span id="P209" epub:type="pagebreak" title="209" />
<h2 class="h1hd" id="sc0255tit">Case 103</h2>
<a id="p7715" />
<div class="boxg1" id="b0500"><a id="p7720" />
<div class="pageavoid" id="f0500"><figure class="fig"><img src="../images/F000027b02-99-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 103-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0505"><figure class="fig"><img src="../images/F000027b02-100-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 103-2</span></figcaption></figure></div>
<section><a id="s2060" /><section><a id="s2065" /><section><a id="s2070" /><section><a id="s2075" />
<p class="b14hd" id="st1800">History</p>
<p id="p7725" class="b1textfl">A 51-year-old female with known metastatic colorectal cancer.<a id="l1480" /></p>
<div><?mpslid S1177?>
<p class="b1numlista" id="o5895"><a id="Case103-1" href="#Case0103-1">1</a>.&#160;<a id="p7730" />A selective angiogram of which vessel is demonstrated in the first image?<a id="l1485" /></p><?mpslid S1178?>
<p class="b1numlist1a" id="o5900">A.&#160;<a id="p7735" />Celiac artery</p><?mpslid E1178?><?mpslid S1179?>
<p class="b1numlist1a" id="o5905">B.&#160;<a id="p7740" />Superior mesenteric artery</p><?mpslid E1179?><?mpslid S1180?>
<p class="b1numlist1a" id="o5910">C.&#160;<a id="p7745" />Common hepatic artery</p><?mpslid E1180?><?mpslid S1181?>
<p class="b1numlist1a" id="o5915">D.&#160;<a id="p7750" />Proper hepatic artery</p><?mpslid E1181?><?mpslid E1177?><?mpslid S1182?>
<p class="b1numlista" id="o5920"><a id="Case103-2" href="#Case0103-2">2</a>.&#160;<a id="p7755" />Transcatheter arterial radioembolization is Food and Drug Administration (FDA)-approved for which of the following? (Choose all that apply.)<a id="l1490" /></p><?mpslid S1183?>
<p class="b1numlist1a" id="o5925">A.&#160;<a id="p7760" />Colorectal metastatic disease to the liver</p><?mpslid E1183?><?mpslid S1184?>
<p class="b1numlist1a" id="o5930">B.&#160;<a id="p7765" />Melanoma metastatic disease to the liver</p><?mpslid E1184?><?mpslid S1185?>
<p class="b1numlist1a" id="o5935">C.&#160;<a id="p7770" />Cholangiocarcinoma</p><?mpslid E1185?><?mpslid S1186?>
<p class="b1numlist1a" id="o5940">D.&#160;<a id="p7775" />Hepatocellular carcinoma</p><?mpslid E1186?><?mpslid E1182?><?mpslid S1187?>
<p class="b1numlista" id="o5945"><a id="Case103-3" href="#Case0103-3">3</a>.&#160;<a id="p7780" />Which, radioisotope is used for transcatheter radioembolization and what particle type does it emit?<a id="l1495" /></p><?mpslid S1188?>
<p class="b1numlist1a" id="o5950">A.&#160;<a id="p7785" />I<sup>131</sup>-beta</p><?mpslid E1188?><?mpslid S1189?>
<p class="b1numlist1a" id="o5955">B.&#160;<a id="p7790" />Y<sup>90</sup>-beta</p><?mpslid E1189?><?mpslid S1190?>
<p class="b1numlist1a" id="o5960">C.&#160;<a id="p7795" />Tc<sup>99</sup>-gamma</p><?mpslid E1190?><?mpslid S1191?>
<p class="b1numlist1a" id="o5965">D.&#160;<a id="p7800" />Sa<sup>153</sup>-beta and gamma</p><?mpslid E1191?><?mpslid E1187?><?mpslid S1192?>
<p class="b1numlista" id="o5970"><a id="Case103-4" href="#Case0103-4">4</a>.&#160;<a id="p7805" />Reflux into which of the following extrahepatic arteries is most likely to cause a nontarget complication from an intrahepatic embolization? (Choose two.)<a id="l1500" /></p><?mpslid S1193?>
<p class="b1numlist1a" id="o5975">A.&#160;<a id="p7810" />Right gastric</p><?mpslid E1193?><?mpslid S1194?>
<p class="b1numlist1a" id="o5980">B.&#160;<a id="p7815" />Left gastric</p><?mpslid E1194?><?mpslid S1195?>
<p class="b1numlist1a" id="o5985">C.&#160;<a id="p7820" />Gastroduodenal</p><?mpslid E1195?><?mpslid S1196?>
<p class="b1numlist1a" id="o5990">D.&#160;<a id="p7825" />Splenic</p><?mpslid E1196?><?mpslid E1192?>
</div>
<p id="p7830" class="b1text">
<a epub:type="noteref" href="#fn0260" id="Cfn0260">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0260">
<a href="#Cfn0260"><sup>*</sup></a><a id="np0260" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0520tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P210" epub:type="pagebreak" title="210" />
<div class="boxg1" id="b0505">
<p class="b1title">Answers</p>
<p class="b1subt">Case 103</p>
<section><a id="s2080" />
<p class="b11hd" id="st1805">Colorectal Metastases to Liver: Radioembolization</p>
<a id="p7835" />
<a id="l1505" />
<div><?mpslid S1197?>
<p class="b1numlista" id="o5995"><a id="Case0103-1" href="#Case103-1">1</a>.&#160;<a id="p7840" /><strong>A.</strong> The first image demonstrates a celiac arteriogram with conventional hepatic arterial anatomy. Many normal variants are possible, but conventional hepatic arterial anatomy includes a common hepatic artery originating from the celiac artery, which becomes the proper hepatic artery and gastroduodenal arteries. The left and right hepatic arteries arise from the proper hepatic artery.</p><?mpslid E1197?><?mpslid S1198?>
<p class="b1numlista" id="o6000"><a id="Case0103-2" href="#Case103-2">2</a>.&#160;<a id="p7845" /><strong>A and D.</strong> Currently, Y<sup>90</sup> treatment is FDA-approved for use in patients with colorectal metastatic disease to the liver or primary hepatocellular carcinoma.</p><?mpslid E1198?><?mpslid S1199?>
<p class="b1numlista" id="o6005"><a id="Case0103-3" href="#Case103-3">3</a>.&#160;<a id="p7850" /><strong>B.</strong> Y<sup>90</sup> is a pure beta-emitter with a half-life of 64.2 hours. The majority of the dose (94%) is delivered within the first 11 days following treatment. The average tissue penetration distance is 2.5&#160;mm.</p><?mpslid E1199?><?mpslid S1200?>
<p class="b1numlista" id="o6010"><a id="Case0103-4" href="#Case103-4">4</a>.&#160;<a id="p7855" /><strong>A and C.</strong> Y<sup>90</sup> reflux is most common into the right gastric and gastroduodenal arteries, which can lead to ischemia and/or radiation enteritis. These arteries are identified on the planning angiogram for potential optimization, either coil embolization or more distal arterial selection prior to radioembolization. Pretreatment evaluation with Tc<sup>99m</sup> macroaggregate albumin (MAA) is used to identify extrahepatic deposition in the gastrointestinal and pulmonary system with subsequent modification of the radioembolization procedure and/or dose calculation.</p><?mpslid E1200?>
</div>
<section><a id="s2085" />
<p class="b12hd" id="st1810">Comment</p>
<section><a id="s2090" />
<p class="b13hd" id="st1815">Preprocedural Planning</p>
<p id="p7860" class="b1textfl">Radioembolization with Y<sup>90</sup> microspheres is an FDA-approved therapy for treating unresectable hepatocellular carcinoma and metastatic colorectal carcinoma to the liver. The microspheres are delivered to the tumors in a transcatheter approach through the hepatic artery and, once in place, emit radiation that acts on the tumor cells. Careful patient selection after cross-sectional imaging review and discussion with patient and referring physician is necessary to obtain optimal results (<a href="chp004_a.xhtml#f2015">Figure S103-2</a>).</p>
</section>
<section><a id="s2095" />
<p class="b13hd" id="st1820">Procedural Technique</p>
<p id="p7865" class="b1textfl">Owing to the variation in hepatic arterial anatomy and the potential complications that can result from nontarget embolization of microspheres to the bowel, gallbladder, pancreas, and other nearby structures that derive part of their arterial supply from branches closely associated with those that supply the liver, careful mapping of the arterial supply to the intended target lesion(s) and optimization of the arterial anatomy by selective embolization of vessels is mandatory (<a href="chp004_a.xhtml#f2010">Figure S103-1</a>). After optimizing the arterial anatomy, the microcatheter tip is placed in the planned position for delivery of the radioembolic microspheres and approximately 5&#160;mCi of Tc<sup>99m</sup>-MAA is delivered through the microcatheter. This is followed by single-photon emission computerized tomography (SPECT) imaging to assess the activity within the liver and to detect any activity in extrahepatic abdominal structures and the lungs to evaluate for nontarget delivery and tumor arteriovenous shunting, respectively (<a href="chp004_a.xhtml#f2020">Figure S103-3</a>). Once the planning images are reviewed and the patient is deemed a candidate for treatment, dosimetry data are calculated. Dosimetry calculation methods vary; however, some factors that are considered include body surface area, liver volume, tumor burden, and underlying liver cirrhosis. The dose delivery must be carefully monitored under fluoroscopy to ensure optimal radioembolization (<a href="chp004_a.xhtml#f2025">Figure S103-4</a>). Some centers perform a follow-up positron emission tomography&#8211;computed tomography (CT) or fused SPECT-CT to assess delivery of the dose (<a href="chp004_a.xhtml#f2030">Figure S103-5</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0255" />
<h3 class="ref2hd" id="st1825">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0815">1. Murthy R, Kamat P, Nunez R, Salem R. Radioembolization of yttrium-90 microspheres for hepatic malignancy. <em>Semin Intervent Rad</em>. 2008;25:48&#8211;57.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0820">2. Salem R, Thurston KG. Radioembolization with yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies Part 1: technical and methodologic considerations. <em>J Vasc Interv Radiol</em>. 2006;17:1251&#8211;1278.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr9220" />
<h3 class="ref2hd" id="st9795">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb9800">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 250&#8211;252.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0260" />
<span id="P211" epub:type="pagebreak" title="211" />
<h2 class="h1hd" id="sc0260tit">Case 104</h2>
<a id="p7870" />
<div class="boxg1" id="b0510"><a id="p7875" />
<div class="pageavoid" id="f0510"><figure class="fig"><img src="../images/F000027b02-101-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 104-1</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0515"><figure class="fig"><img src="../images/F000027b02-102-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 104-2</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<section><a id="s2100" /><section><a id="s2105" /><section><a id="s2110" /><section><a id="s2115" />
<p class="b14hd" id="st1830">History</p>
<p id="p7880" class="b1textfl">A 60-year-old female with shortness of breath.<a id="l1510" /></p>
<div><?mpslid S1201?>
<p class="b1numlista" id="o6015"><a id="Case104-1" href="#Case0104-1">1</a>.&#160;<a id="p7885" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1515" /></p><?mpslid S1202?>
<p class="b1numlist1a" id="o6020">A.&#160;<a id="p7890" />Mesothelioma</p><?mpslid E1202?><?mpslid S1203?>
<p class="b1numlist1a" id="o6025">B.&#160;<a id="p7895" />Parapneumonic pleural effusion</p><?mpslid E1203?><?mpslid S1204?>
<p class="b1numlist1a" id="o6030">C.&#160;<a id="p7900" />Localized fibrous tumor of the pleura</p><?mpslid E1204?><?mpslid S1205?>
<p class="b1numlist1a" id="o6035">D.&#160;<a id="p7905" />Transudative pleural effusion</p><?mpslid E1205?><?mpslid E1201?><?mpslid S1206?>
<p class="b1numlista" id="o6040"><a id="Case104-2" href="#Case0104-2">2</a>.&#160;<a id="p7910" />What is the most common symptom in patients presenting with malignant pleural effusion?<a id="l1520" /></p><?mpslid S1207?>
<p class="b1numlist1a" id="o6045">A.&#160;<a id="p7915" />Chest pain</p><?mpslid E1207?><?mpslid S1208?>
<p class="b1numlist1a" id="o6050">B.&#160;<a id="p7920" />Hemoptysis</p><?mpslid E1208?><?mpslid S1209?>
<p class="b1numlist1a" id="o6055">C.&#160;<a id="p7925" />Fever</p><?mpslid E1209?><?mpslid S1210?>
<p class="b1numlist1a" id="o6060">D.&#160;<a id="p7930" />Dyspnea</p><?mpslid E1210?><?mpslid E1206?><?mpslid S1211?>
<p class="b1numlista" id="o6065"><a id="Case104-3" href="#Case0104-3">3</a>.&#160;<a id="p7935" />Which of the following is <em>NOT</em> a computed tomography (CT) imaging feature of malignant pleural disease?<a id="l1525" /></p><?mpslid S1212?>
<p class="b1numlist1a" id="o6070">A.&#160;<a id="p7940" />Circumferential pleural thickening</p><?mpslid E1212?><?mpslid S1213?>
<p class="b1numlist1a" id="o6075">B.&#160;<a id="p7945" />Smooth pleural thickening</p><?mpslid E1213?><?mpslid S1214?>
<p class="b1numlist1a" id="o6080">C.&#160;<a id="p7950" />Parietal pleural thickening greater than 1&#160;cm</p><?mpslid E1214?><?mpslid S1215?>
<p class="b1numlist1a" id="o6085">D.&#160;<a id="p7955" />Mediastinal pleura involvement</p><?mpslid E1215?><?mpslid E1211?><?mpslid S1216?>
<p class="b1numlista" id="o6090"><a id="Case104-4" href="#Case0104-4">4</a>.&#160;<a id="p7960" />What is the most common treatment for prompt relief of symptomatic patients with malignant pleural effusion?<a id="l1530" /></p><?mpslid S1217?>
<p class="b1numlist1a" id="o6095">A.&#160;<a id="p7965" />Pleuroperitoneal shunt</p><?mpslid E1217?><?mpslid S1218?>
<p class="b1numlist1a" id="o6100">B.&#160;<a id="p7970" />Pleurodesis</p><?mpslid E1218?><?mpslid S1219?>
<p class="b1numlist1a" id="o6105">C.&#160;<a id="p7975" />Tunneled pleural catheter (TPC)</p><?mpslid E1219?><?mpslid S1220?>
<p class="b1numlist1a" id="o6110">D.&#160;<a id="p7980" />Pleurectomy</p><?mpslid E1220?><?mpslid E1216?>
</div>
<p id="p7985" class="b1text">
<a epub:type="noteref" href="#fn0265" id="Cfn0265">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0265">
<a href="#Cfn0265"><sup>*</sup></a><a id="np0265" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0525tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P212" epub:type="pagebreak" title="212" />
<div class="boxg1" id="b0515">
<p class="b1title">Answers</p>
<p class="b1subt">Case 104</p>
<section><a id="s2120" />
<p class="b11hd" id="st1835">Malignant Pleural Effusion</p>
<a id="p7990" />
<a id="l1535" />
<div><?mpslid S1221?>
<p class="b1numlista" id="o6115"><a id="Case0104-1" href="#Case104-1">1</a>.&#160;<a id="p7995" /><strong>A.</strong> Contrast-enhanced CT images show right pleural effusion and circumferential pleural thickening with mediastinal involvement, findings indicative of malignant pleural disease such as mesothelioma. Metastatic pleural involvement may present similar imaging findings. Parapneumonic pleural effusion, transudative pleural effusion&#8212;as seen on congestive heart failure&#8212;and fibrous tumor of the pleura are benign entities.</p><?mpslid E1221?><?mpslid S1222?>
<p class="b1numlista" id="o6120"><a id="Case0104-2" href="#Case104-2">2</a>.&#160;<a id="p8000" /><strong>D.</strong> Dyspnea is the most common symptom in patients with pleural effusion as the lung has less space to expand. However, patients may also present with low-grade fever or cough.</p><?mpslid E1222?><?mpslid S1223?>
<p class="b1numlista" id="o6125"><a id="Case0104-3" href="#Case104-3">3</a>.&#160;<a id="p8005" /><strong>B.</strong> Nodular or circumferential pleural thickening, parietal pleural thickening greater than 1&#160;cm, and mediastinal pleura involvement are CT imaging features helpful in distinguishing malignant from benign pleural disease (smooth pleural thickening).</p><?mpslid E1223?><?mpslid S1224?>
<p class="b1numlista" id="o6130"><a id="Case0104-4" href="#Case104-4">4</a>.&#160;<a id="p8010" /><strong>C.</strong> The management of malignant pleural effusion has been trending recently toward minimally invasive procedures by placement of TPCs. Ninety percent of patients experience relief of dyspnea within 48 hours.</p><?mpslid E1224?>
</div>
<section><a id="s2125" />
<p class="b12hd" id="st1840">Comment</p>
<section><a id="s2130" />
<p class="b13hd" id="st1845">Clinical Presentation</p>
<p id="p8015" class="b1textfl">Pleural effusion often complicates the course of malignant pleural disease, either primary pleural neoplasm or secondary to metastatic involvement, and is a poor prognostic indicator. The impact on patients' quality of life is significant, and the most common symptom is dyspnea.</p>
</section>
<section><a id="s2135" />
<p class="b13hd" id="st1850">Diagnostic Imaging</p>
<p id="p8020" class="b1textfl">CT provides detailed information on morphological changes associated with pleural effusion. Nodular or circumferential pleural thickening, parietal pleural thickening greater than 1&#160;cm, and mediastinal pleura involvement are CT imaging features helpful in distinguishing malignant from benign pleural disease (<a href="chp004_a.xhtml#f2035">Figure S104-1</a>). Positron emission tomography has proven to have significantly higher diagnostic accuracy compared to CT in detecting malignant pleural disease (<a href="chp004_a.xhtml#f2045">Figure S104-3</a>).</p>
</section>
<section><a id="s2140" />
<p class="b13hd" id="st1855">Management Options</p>
<p id="p8025" class="b1textfl">The approach to management is a palliative one and has traditionally been by thoracostomy and pleurodesis. More recently, management has been trending toward minimally invasive procedures by placement of TPCs (<a href="chp004_a.xhtml#f2040">Figure S104-2</a>). Ultrasound or fluoroscopic guidance is used for accessing the pleural cavity, and the catheter is placed through a peel-away sheath and subsequently tunneled in the subcutaneous tissues of the chest. The catheter has a one-way valve that prevents leakage of pleural fluid from the catheter when it is not connected to a drainage flask and also prevents the entry of air into the pleural cavity through the catheter.</p>
<p id="p8030" class="b1text">Ninety percent of patients experience relief of dyspnea within 48 hours. Spontaneous pleurodesis can occur in up to 46% of patients, usually within a month of placement. Chemical sclerotherapy through the catheter can be used to increase the rate of pleurodesis. If pleurodesis is achieved, the catheter may be removed.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0260" />
<h3 class="ref2hd" id="st1860">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0825">1. Leung AN, M&#252;ller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. <em>Am J Roentgenol</em>. 1990;154(3):487&#8211;492.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0830">2. Orki A, Akin O, Tasci AE, et al. The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases. <em>Thorac Cardiovasc Surg</em>. 2009;57(4):217&#8211;221.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0835">3. Pollak JS. Malignant pleural effusions: treatment with tunneled long-term drainage catheters. <em>Curr Opin Pulm Med</em>. 2002;8:302&#8211;307.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0840">4. Pollak JS, Burdge CM, Rosenblatt M, et al. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. <em>J Vasc Interv Radiol</em>. 2001;12:201&#8211;208.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr9820" />
<h3 class="ref2hd" id="st9895">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb9805">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 418&#8211;423.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0265" />
<span id="P213" epub:type="pagebreak" title="213" />
<h2 class="h1hd" id="sc0265tit">Case 105</h2>
<a id="p8035" />
<div class="boxg1" id="b0520"><a id="p8040" />
<div class="pageavoid" id="f0520"><figure class="fig"><img src="../images/F000027b02-103-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 105-1</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0525"><figure class="fig"><img src="../images/F000027b02-104-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 105-2</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<section><a id="s2145" /><section><a id="s2150" /><section><a id="s2155" /><section><a id="s2160" />
<p class="b14hd" id="st1865">History</p>
<p id="p8045" class="b1textfl">A 78-year-old woman presents with right lower extremity claudication. Conventional angiography and balloon angioplasty were performed. Images were taken following balloon angioplasty.<a id="l1540" /></p>
<div><?mpslid S1225?>
<p class="b1numlista" id="o6135"><a id="Case105-1" href="#Case0105-1">1</a>.&#160;<a id="p8050" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1545" /></p><?mpslid S1226?>
<p class="b1numlist1a" id="o6140">A.&#160;<a id="p8055" />Stenosis</p><?mpslid E1226?><?mpslid S1227?>
<p class="b1numlist1a" id="o6145">B.&#160;<a id="p8060" />Occlusion</p><?mpslid E1227?><?mpslid S1228?>
<p class="b1numlist1a" id="o6150">C.&#160;<a id="p8065" />Dissection</p><?mpslid E1228?><?mpslid S1229?>
<p class="b1numlist1a" id="o6155">D.&#160;<a id="p8070" />Aneurysm</p><?mpslid E1229?><?mpslid E1225?><?mpslid S1230?>
<p class="b1numlista" id="o6160"><a id="Case105-2" href="#Case0105-2">2</a>.&#160;<a id="p8075" />Which of the following systolic (arterial) pressure gradients would represent a clinically significant gradient?<a id="l1550" /></p><?mpslid S1231?>
<p class="b1numlist1a" id="o6165">A.&#160;<a id="p8080" />2&#160;mm&#160;Hg</p><?mpslid E1231?><?mpslid S1232?>
<p class="b1numlist1a" id="o6170">B.&#160;<a id="p8085" />6&#160;mm&#160;Hg</p><?mpslid E1232?><?mpslid S1233?>
<p class="b1numlist1a" id="o6175">C.&#160;<a id="p8090" />9&#160;mm&#160;Hg</p><?mpslid E1233?><?mpslid S1234?>
<p class="b1numlist1a" id="o6180">D.&#160;<a id="p8095" />12&#160;mm&#160;Hg</p><?mpslid E1234?><?mpslid E1230?><?mpslid S1235?>
<p class="b1numlista" id="o6185"><a id="Case105-3" href="#Case0105-3">3</a>.&#160;<a id="p8100" />Which of the following techniques are <em>NOT</em> used to correct the disease shown in the image?<a id="l1555" /></p><?mpslid S1236?>
<p class="b1numlist1a" id="o6190">A.&#160;<a id="p8105" />Blood pressure control without further intervention</p><?mpslid E1236?><?mpslid S1237?>
<p class="b1numlist1a" id="o6195">B.&#160;<a id="p8110" />Prolonged balloon angioplasty</p><?mpslid E1237?><?mpslid S1238?>
<p class="b1numlist1a" id="o6200">C.&#160;<a id="p8115" />Balloon fenestration</p><?mpslid E1238?><?mpslid S1239?>
<p class="b1numlist1a" id="o6205">D.&#160;<a id="p8120" />Stent placement</p><?mpslid E1239?><?mpslid E1235?><?mpslid S1240?>
<p class="b1numlista" id="o6210"><a id="Case105-4" href="#Case0105-4">4</a>.&#160;<a id="p8125" />Which of the following are risk factors for arterial dissection?<a id="l1560" /></p><?mpslid S1241?>
<p class="b1numlist1a" id="o6215">A.&#160;<a id="p8130" />Obesity</p><?mpslid E1241?><?mpslid S1242?>
<p class="b1numlist1a" id="o6220">B.&#160;<a id="p8135" />Hypertension</p><?mpslid E1242?><?mpslid S1243?>
<p class="b1numlist1a" id="o6225">C.&#160;<a id="p8140" />Hypercalcemia</p><?mpslid E1243?><?mpslid S1244?>
<p class="b1numlist1a" id="o6230">D.&#160;<a id="p8145" />Alcohol use</p><?mpslid E1244?><?mpslid E1240?>
</div>
<p id="p8150" class="b1text">
<a epub:type="noteref" href="#fn0270" id="Cfn0270">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0270">
<a href="#Cfn0270"><sup>*</sup></a><a id="np0270" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0530tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P214" epub:type="pagebreak" title="214" />
<div class="boxg1" id="b0525">
<p class="b1title">Answers</p>
<p class="b1subt">Case 105</p>
<section><a id="s2165" />
<p class="b11hd" id="st1870">Iatrogenic Superficial Femoral Artery Dissection</p>
<a id="p8155" />
<a id="l1565" />
<div><?mpslid S1245?>
<p class="b1numlista" id="o6235"><a id="Case0105-1" href="#Case105-1">1</a>.&#160;<a id="p8160" /><strong>C.</strong> Digital subtraction angiography of the superficial femoral artery (SFA) demonstrates a dissection flap, which has resulted in greater than 50% decrease in flow distal to the lesion. Iatrogenic arterial dissection typically occurs at the time of needle puncture, during dilation of an arterial stenosis, or during attempts to cross high-grade stenoses or occlusions.</p><?mpslid E1245?><?mpslid S1246?>
<p class="b1numlista" id="o6240"><a id="Case0105-2" href="#Case105-2">2</a>.&#160;<a id="p8165" /><strong>D.</strong> A systolic pressure gradient of 10&#160;mm&#160;Hg or greater signifies a flow-limiting lesion.</p><?mpslid E1246?><?mpslid S1247?>
<p class="b1numlista" id="o6245"><a id="Case0105-3" href="#Case105-3">3</a>.&#160;<a id="p8170" /><strong>A.</strong> The majority of arterial dissections resolve spontaneously without the need for percutaneous or surgical treatment. Flow-limiting dissections, however, require acute intervention with surgery or intervention. Shorter lesions (less than 10&#160;cm) within the SFA are commonly managed with prolonged balloon angioplasty with or without stent placement or balloon fenestration, while longer lesions may require femoral-popliteal bypass with interposed saphenous vein stent or a graft.</p><?mpslid E1247?><?mpslid S1248?>
<p class="b1numlista" id="o6250"><a id="Case0105-4" href="#Case105-4">4</a>.&#160;<a id="p8175" /><strong>B.</strong> Risk factors for arterial dissection include trauma, collagen vascular diseases (Ehler-Danlos syndrome, Marfan syndrome, cystic medial sclerosis, fibromuscular dysplasia), preexisting aneurysm, and the typical cardiovascular risk factors (hypertension, smoking, diabetes mellitus, hyperlipidemia).</p><?mpslid E1248?>
</div>
<section><a id="s2170" />
<p class="b12hd" id="st1875">Comment</p>
<section><a id="s2175" />
<p class="b13hd" id="st1880">Main Teaching Point</p>
<p id="p8180" class="b1textfl">Repeat angiography is always performed immediately following angioplasty in order to assess whether the stenosis has been adequately treated and to evaluate for any complications (<a href="chp004_a.xhtml#f2050">Figure S105-1</a>). It is wise to perform angiography in two projections because intimal dissection flaps oriented in the coronal plane might not be appreciated on a single anteroposterior view. Postangioplasty pressure measurements across the lesion may also be obtained: If an unexplained significant (&#62;&#160;10&#160;mm&#160;Hg) systolic pressure gradient is still present, the presence of occult dissection should be suspected. Intravascular ultrasound, when available, can be extremely helpful in clarifying whether this is indeed the case and in assessing the entire extent of the dissection process.</p>
</section>
<section><a id="s2180" />
<p class="b13hd" id="st1885">Endovascular Management</p>
<p id="p8185" class="b1textfl">Dissections caused by retrograde passage of a guide-wire in a false channel often resolve spontaneously. Anterograde dissections are more likely to extend and to occlude flow. Flow-limiting dissections (dissections resulting in &#62;&#160;10&#160;mm&#160;Hg systolic pressure gradient across the lesion or &#62;&#160;50% stenosis) require urgent treatment to prevent thrombosis. Most iliac artery dissections that do not extend into the common femoral artery can be managed with balloon angioplasty and stent placement (<a href="chp004_a.xhtml#f2055">Figures S105-2</a> through <a href="chp004_a.xhtml#f2065">S105-4</a>). Surgical bypass may be a management choice if the patient is thought to be able to tolerate a surgical procedure rather than stent placement.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0265" />
<h3 class="ref2hd" id="st1890">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0845">1. Fornaro J, Meier T, Pfammatter T. Percutaneous balloon fenestration of flow-limiting iatrogenic dissection of the common femoral artery: report of two cases. <em>J Vasc Interv Radiol</em>. 2010;21:1115&#8211;1118.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0850">2. Funaki B. Iatrogenic flow-limiting arterial dissection. <em>Semin Intervent Rad</em>. 2008;25:437&#8211;441.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0225" />
<h3 class="ref2hd" id="st1895">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0855">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 347&#8211;351.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0270" />
<span id="P215" epub:type="pagebreak" title="215" />
<h2 class="h1hd" id="sc0270tit">Case 106</h2>
<a id="p8190" />
<div class="boxg1" id="b0530"><a id="p8195" />
<div class="pageavoid" id="f0530"><figure class="fig"><img src="../images/F000027b02-105-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 106-1</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0535"><figure class="fig"><img src="../images/F000027b02-106-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 106-2</span> <span class="figcredit">Courtesy of Dr. Wael E. Saad.</span>
</figcaption>
</figure>
</div>
<section><a id="s2185" /><section><a id="s2190" /><section><a id="s2195" /><section><a id="s2200" />
<p class="b14hd" id="st1900">History</p>
<p id="p8200" class="b1textfl">A 40-year-old woman with history of menorrhagia from fibroids presents with continued bleeding, 9 months post uterine artery embolization (UAE).<a id="l1570" /></p>
<div><?mpslid S1249?>
<p class="b1numlista" id="o6255"><a id="Case106-1" href="#Case0106-1">1</a>.&#160;<a id="p8205" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1575" /></p><?mpslid S1250?>
<p class="b1numlist1a" id="o6260">A.&#160;<a id="p8210" />Nutcracker syndrome</p><?mpslid E1250?><?mpslid S1251?>
<p class="b1numlist1a" id="o6265">B.&#160;<a id="p8215" />Leriche syndrome</p><?mpslid E1251?><?mpslid S1252?>
<p class="b1numlist1a" id="o6270">C.&#160;<a id="p8220" />Pelvic congestion syndrome</p><?mpslid E1252?><?mpslid S1253?>
<p class="b1numlist1a" id="o6275">D.&#160;<a id="p8225" />Extrauterine arterial perfusion of fibroids</p><?mpslid E1253?><?mpslid E1249?><?mpslid S1254?>
<p class="b1numlista" id="o6280"><a id="Case106-2" href="#Case0106-2">2</a>.&#160;<a id="p8230" />Which abnormal artery is depicted in the second image?<a id="l1580" /></p><?mpslid S1255?>
<p class="b1numlist1a" id="o6285">A.&#160;<a id="p8235" />Inferior epigastric artery</p><?mpslid E1255?><?mpslid S1256?>
<p class="b1numlist1a" id="o6290">B.&#160;<a id="p8240" />Iliolumbar artery</p><?mpslid E1256?><?mpslid S1257?>
<p class="b1numlist1a" id="o6295">C.&#160;<a id="p8245" />Ovarian artery</p><?mpslid E1257?><?mpslid S1258?>
<p class="b1numlist1a" id="o6300">D.&#160;<a id="p8250" />Inferior mesenteric artery</p><?mpslid E1258?><?mpslid E1254?><?mpslid S1259?>
<p class="b1numlista" id="o6305"><a id="Case106-3" href="#Case0106-3">3</a>.&#160;<a id="p8255" />Can this vessel be safely embolized for effective treatment of fibroids?<a id="l1585" /></p><?mpslid S1260?>
<p class="b1numlist1a" id="o6310">A.&#160;<a id="p8260" />Yes, patients generally have no increased side effects compared with normal UAE.</p><?mpslid E1260?><?mpslid S1261?>
<p class="b1numlist1a" id="o6315">B.&#160;<a id="p8265" />Yes, but patients frequently go into premature menopause.</p><?mpslid E1261?><?mpslid S1262?>
<p class="b1numlist1a" id="o6320">C.&#160;<a id="p8270" />No, because embolizing this vessel is unlikely to affect fibroid perfusion.</p><?mpslid E1262?><?mpslid S1263?>
<p class="b1numlist1a" id="o6325">D.&#160;<a id="p8275" />No, because it will infarct the ovary.</p><?mpslid E1263?><?mpslid E1259?><?mpslid S1264?>
<p class="b1numlista" id="o6330"><a id="Case106-4" href="#Case0106-4">4</a>.&#160;<a id="p8280" />For which symptom is UAE most effective?<a id="l1590" /></p><?mpslid S1265?>
<p class="b1numlist1a" id="o6335">A.&#160;<a id="p8285" />Menorrhagia</p><?mpslid E1265?><?mpslid S1266?>
<p class="b1numlist1a" id="o6340">B.&#160;<a id="p8290" />Dysuria</p><?mpslid E1266?><?mpslid S1267?>
<p class="b1numlist1a" id="o6345">C.&#160;<a id="p8295" />Constipation</p><?mpslid E1267?><?mpslid S1268?>
<p class="b1numlist1a" id="o6350">D.&#160;<a id="p8300" />Sciatica</p><?mpslid E1268?><?mpslid E1264?>
</div>
<p id="p8305" class="b1text">
<a epub:type="noteref" href="#fn0275" id="Cfn0275">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0275">
<a href="#Cfn0275"><sup>*</sup></a><a id="np0275" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0535tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P216" epub:type="pagebreak" title="216" />
<div class="boxg1" id="b0535">
<p class="b1title">Answers</p>
<p class="b1subt">Case 106</p>
<section><a id="s2205" />
<p class="b11hd" id="st1905">Ovarian Artery Embolization</p>
<a id="p8310" />
<a id="l1595" />
<div><?mpslid S1269?>
<p class="b1numlista" id="o6355"><a id="Case0106-1" href="#Case106-1">1</a>.&#160;<a id="p8315" /><strong>D.</strong> The aortogram and delay pelvic image clearly demonstrate a hypertrophied and tortuous ovarian artery with parenchymal blush in the uterus.</p><?mpslid E1269?><?mpslid S1270?>
<p class="b1numlista" id="o6360"><a id="Case0106-2" href="#Case106-2">2</a>.&#160;<a id="p8320" /><strong>C.</strong> The tortuous vessel coursing inferiorly from the abdominal aorta into the pelvis is the right ovarian artery.</p><?mpslid E1270?><?mpslid S1271?>
<p class="b1numlista" id="o6365"><a id="Case0106-3" href="#Case106-3">3</a>.&#160;<a id="p8325" /><strong>A.</strong> Ovarian artery embolization for fibroid treatment has been shown to be both effective and to generally have no additional symptoms above and beyond those seen with conventional UAE. Patients may enter menopause early, but not frequently.</p><?mpslid E1271?><?mpslid S1272?>
<p class="b1numlista" id="o6370"><a id="Case0106-4" href="#Case106-4">4</a>.&#160;<a id="p8330" /><strong>A.</strong> Dysfunctional uterine bleeding is more likely to respond to UAE than bulk symptoms; therefore, careful patient selection is key to maximize patient satisfaction with the result.</p><?mpslid E1272?>
</div>
<section><a id="s2210" />
<p class="b12hd" id="st1910">Comment</p>
<section><a id="s2215" />
<p class="b13hd" id="st1915">Main Teaching Point</p>
<p id="p8335" class="b1textfl">UAE has been shown to improve menorrhagia symptoms and pelvic pain in 85% to 90% of patients. There are several potential reasons why a patient may not demonstrate clinical response after embolization. One potential reason is incomplete bilateral embolization. The most common reason this might occur is when arterial spasm-related slow flow in the uterine artery deceives the angiographer into believing that embolization has been achieved. Another common reason is the presence of additional blood supply to the fibroid uterus. This can result from congenital variations in uterine artery anatomy or from pelvic collateral supply.</p>
</section>
<section><a id="s2220" />
<p class="b13hd" id="st1920">Imaging Interpretation</p>
<p id="p8340" class="b1textfl">The images here demonstrate the most common source of extrauterine supply to the uterus: an enlarged ovarian artery. In the aortogram, there is a highly tortuous artery coursing along the right side of the aorta, the ovarian artery (<a href="chp004_a.xhtml#f2070">Figure S106-1</a>). The second image demonstrates an enlarged right ovarian artery with blush of the uterine fibroid (<a href="chp004_a.xhtml#f2075">Figure S106-2</a>). Many interventional radiologists perform an abdominal and pelvic aortogram following UAE in order to evaluate for residual perfusion of the fibroids from an ovarian artery (<a href="chp004_a.xhtml#f2080">Figures S106-3</a> through <a href="chp004_a.xhtml#f2090">S106-5</a>).</p>
</section>
<section><a id="s2225" />
<p class="b13hd" id="st1925">Endovascular Management</p>
<p id="p8345" class="b1textfl">Fortunately, the ovarian artery can also be embolized. Most interventionalists embolize the main ovarian artery using Gelfoam, although some advance a microcatheter beyond the ovary and attempt subselective embolization of the uterine branches.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0270" />
<h3 class="ref2hd" id="st1930">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0860">1. Bulman J, Ascher S, Spies J. Current concepts in uterine fibroid embolization. <em>Radiographics</em>. 2012;32:1735&#8211;1750.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0865">2. Pelage JP, Walker WJ, Le Dref O, et al. Ovarian artery: angiographic appearance, embolization and relevance to uterine fibroid embolization. <em>Cardiovasc Intervent Radiol</em>. 2003;26:227&#8211;233.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0870">3. Worthington-Kirsch RL, Andrews RT, Siskin GP, et al. Uterine fibroid embolization: technical aspects. <em>Tech Vasc Interv Radiol</em>. 2002;5:17&#8211;34.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0230" />
<h3 class="ref2hd" id="st1935">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0875">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 222&#8211;225.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0275" />
<span id="P217" epub:type="pagebreak" title="217" />
<h2 class="h1hd" id="sc0275tit">Case 107</h2>
<a id="p8350" />
<div class="boxg1" id="b0540"><a id="p8355" />
<div class="pageavoid" id="f0540"><figure class="fig"><img src="../images/F000027b02-107-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 107-1</span></figcaption></figure></div>
<div class="pageavoid" id="f0545"><figure class="fig"><img src="../images/F000027b02-108-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 107-2</span></figcaption></figure></div>
<section><a id="s2230" /><section><a id="s2235" /><section><a id="s2240" /><section><a id="s2245" />
<p class="b14hd" id="st1940">History</p>
<p id="p8360" class="b1textfl">A 59-year-old male with recent diagnosis of lung cancer presents with shortness of breath.<a id="l1600" /></p>
<div><?mpslid S1273?>
<p class="b1numlista" id="o6375"><a id="Case107-1" href="#Case0107-1">1</a>.&#160;<a id="p8365" />Which of the following is the most likely diagnosis for the imaging finding presented on the left image?<a id="l1605" /></p><?mpslid S1274?>
<p class="b1numlist1a" id="o6380">A.&#160;<a id="p8370" />Thrombosed inferior vena cava (IVC) filter</p><?mpslid E1274?><?mpslid S1275?>
<p class="b1numlist1a" id="o6385">B.&#160;<a id="p8375" />Chronic deep vein thrombosis (DVT)</p><?mpslid E1275?><?mpslid S1276?>
<p class="b1numlist1a" id="o6390">C.&#160;<a id="p8380" />Free-floating IVC thrombus</p><?mpslid E1276?><?mpslid S1277?>
<p class="b1numlist1a" id="o6395">D.&#160;<a id="p8385" />Atherosclerosis</p><?mpslid E1277?><?mpslid E1273?><?mpslid S1278?>
<p class="b1numlista" id="o6400"><a id="Case107-2" href="#Case0107-2">2</a>.&#160;<a id="p8390" />Which of the following is an indication for the placement of an IVC filter?<a id="l1610" /></p><?mpslid S1279?>
<p class="b1numlist1a" id="o6405">A.&#160;<a id="p8395" />Upper-extremity DVT</p><?mpslid E1279?><?mpslid S1280?>
<p class="b1numlist1a" id="o6410">B.&#160;<a id="p8400" />Factor V Leiden deficiency</p><?mpslid E1280?><?mpslid S1281?>
<p class="b1numlist1a" id="o6415">C.&#160;<a id="p8405" />Free-floating iliofemoral or IVC thrombus</p><?mpslid E1281?><?mpslid S1282?>
<p class="b1numlist1a" id="o6420">D.&#160;<a id="p8410" />Septic pulmonary emboli</p><?mpslid E1282?><?mpslid E1278?><?mpslid S1283?>
<p class="b1numlista" id="o6425"><a id="Case107-3" href="#Case0107-3">3</a>.&#160;<a id="p8415" />If an IVC filter is being placed in this case, what access site should be used?<a id="l1615" /></p><?mpslid S1284?>
<p class="b1numlist1a" id="o6430">A.&#160;<a id="p8420" />Left common femoral vein</p><?mpslid E1284?><?mpslid S1285?>
<p class="b1numlist1a" id="o6435">B.&#160;<a id="p8425" />Right common femoral vein</p><?mpslid E1285?><?mpslid S1286?>
<p class="b1numlist1a" id="o6440">C.&#160;<a id="p8430" />Left internal jugular vein</p><?mpslid E1286?><?mpslid S1287?>
<p class="b1numlist1a" id="o6445">D.&#160;<a id="p8435" />Right internal jugular vein</p><?mpslid E1287?><?mpslid E1283?><?mpslid S1288?>
<p class="b1numlista" id="o6450"><a id="Case107-4" href="#Case0107-4">4</a>.&#160;<a id="p8440" />Where would you place an IVC filter in this patient?<a id="l1620" /></p><?mpslid S1289?>
<p class="b1numlist1a" id="o6455">A.&#160;<a id="p8445" />In the right common iliac vein</p><?mpslid E1289?><?mpslid S1290?>
<p class="b1numlist1a" id="o6460">B.&#160;<a id="p8450" />In the infrarenal IVC</p><?mpslid E1290?><?mpslid S1291?>
<p class="b1numlist1a" id="o6465">C.&#160;<a id="p8455" />In the suprarenal IVC</p><?mpslid E1291?><?mpslid S1292?>
<p class="b1numlist1a" id="o6470">D.&#160;<a id="p8460" />There is no indication for IVC filter placement.</p><?mpslid E1292?><?mpslid E1288?>
</div>
<p id="p8465" class="b1text">
<a epub:type="noteref" href="#fn0280" id="Cfn0280">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0280">
<a href="#Cfn0280"><sup>*</sup></a><a id="np0280" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0540tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P218" epub:type="pagebreak" title="218" />
<div class="boxg1" id="b0545">
<p class="b1title">Answers</p>
<p class="b1subt">Case 107</p>
<section><a id="s2250" />
<p class="b11hd" id="st1945">Free-Floating IVC Thrombus</p>
<a id="p8470" />
<a id="l1625" />
<div><?mpslid S1293?>
<p class="b1numlista" id="o6475"><a id="Case0107-1" href="#Case107-1">1</a>.&#160;<a id="p8475" /><strong>C.</strong> There is a large ovoid filling defect within the right iliac vein extending into the IVC, consistent with a large free-floating acute thrombus. The appearance does not suggest a chronic DVT. There is no intraluminal stenosis or narrowing to suggest atherosclerosis. No radiopaque object with the appearance of an IVC filter with thrombosis is seen in the image.</p><?mpslid E1293?><?mpslid S1294?>
<p class="b1numlista" id="o6480"><a id="Case0107-2" href="#Case107-2">2</a>.&#160;<a id="p8480" /><strong>C.</strong> The presence of a free-floating iliofemoral or IVC thrombus is a valid indication for placement of an IVC filter. The other answer choices, upper-extremity DVT, Factor V Leiden deficiency, and septic pulmonary emboli, are not definite indications for placement of an IVC filter.</p><?mpslid E1294?><?mpslid S1295?>
<p class="b1numlista" id="o6485"><a id="Case0107-3" href="#Case107-3">3</a>.&#160;<a id="p8485" /><strong>D.</strong> The right internal jugular vein would be the best, most straightforward access point for placement of the IVC filter. The next best options are the left common femoral vein and left internal jugular veins. The right common femoral vein would be a poor access site as catheter and guidewire manipulation could potentially cause distal embolization of the clot leading to life-threatening pulmonary embolism.</p><?mpslid E1295?><?mpslid S1296?>
<p class="b1numlista" id="o6490"><a id="Case0107-4" href="#Case107-4">4</a>.&#160;<a id="p8490" /><strong>C.</strong> It is generally preferable to place the filter in the IVC at the level of the most inferior renal vein such that the apex of the filter is at or just above the lower lip of the renal vein. It is thought that the high flow from the renal veins bathes the apex and helps prevent filter thrombosis. Some postulate that endogenous substances (such as urokinase), produced in the kidneys and subsequently carried in the renal veins, also help prevent thrombosis of the filter. However, in this case, the proximal aspect of the thrombus extends to the level of the left renal vein, preventing placement at this location. Therefore, the IVC filter should be placed between the renal veins and hepatic veins within the suprarenal IVC as is shown in the image on the right.</p><?mpslid E1296?>
</div>
<section><a id="s2255" />
<p class="b12hd" id="st1950">Comment</p>
<section><a id="s2260" />
<p class="b13hd" id="st1955">Main Teaching Point</p>
<p id="p8495" class="b1textfl">The images demonstrate a large ovoid filling defect within the right iliac vein extending into the IVC, consistent with a large free-floating acute thrombus (<a href="chp004_a.xhtml#f2095">Figure S107-1</a>). The venographic appearance of this abnormality suggests a predilection for easy migration and embolization. This necessitates extreme care if catheter manipulations are performed in this region, either for IVC filter placement or for thrombolytic therapy (<a href="chp004_a.xhtml#f2100">Figure S107-2</a>). Free-floating iliac vein and/or IVC thrombus is considered an indication for filter placement, even if no other contraindications to anticoagulation exist. In appropriate clinical scenarios, more aggressive endovascular treatments options, such as catheter-directed thrombolysis and suction thrombectomy, may be employed.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0275" />
<h3 class="ref2hd" id="st1960">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0880">1. Kinney TB. Inferior vena cava filters. <em>Semin Intervent Rad</em>. 2006;23:230&#8211;239.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0885">2. Proctor MC. Indications for filter placement. <em>Semin Vasc Surg</em>. 2000;13:194&#8211;198.</p>
</section>
</section>
<section epub:type="bibliography"><a id="bi0280" />
<h3 class="ref2hd" id="st1965">Cross-reference</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0890">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 293&#8211;300.</p>
</section>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0280" />
<span id="P219" epub:type="pagebreak" title="219" />
<h2 class="h1hd" id="sc0280tit">Case 108</h2>
<a id="p8500" />
<div class="boxg1" id="b0550"><a id="p8505" />
<div class="pageavoid" id="f0550"><figure class="fig"><img src="../images/F000027b02-109-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 108-1</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0555"><figure class="fig"><img src="../images/F000027b02-110-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 108-2</span> <span class="figcredit">Courtesy of Dr. Narasimham L. Dasika.</span>
</figcaption>
</figure>
</div>
<section><a id="s2265" /><section><a id="s2270" /><section><a id="s2275" /><section><a id="s2280" />
<p class="b14hd" id="st1970">History</p>
<p id="p8510" class="b1textfl">A 72-year-old male with diabetes mellitus presents with claudication.<a id="l1630" /></p>
<div><?mpslid S1297?>
<p class="b1numlista" id="o6495"><a id="Case108-1" href="#Case0108-1">1</a>.&#160;<a id="p8515" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1635" /></p><?mpslid S1298?>
<p class="b1numlist1a" id="o6500">A.&#160;<a id="p8520" />Tibial arterial atherosclerotic disease</p><?mpslid E1298?><?mpslid S1299?>
<p class="b1numlist1a" id="o6505">B.&#160;<a id="p8525" />Acute lower-extremity arterial emboli</p><?mpslid E1299?><?mpslid S1300?>
<p class="b1numlist1a" id="o6510">C.&#160;<a id="p8530" />Congenital absence of bilateral posterior arteries</p><?mpslid E1300?><?mpslid S1301?>
<p class="b1numlist1a" id="o6515">D.&#160;<a id="p8535" />Deep venous thrombosis</p><?mpslid E1301?><?mpslid E1297?><?mpslid S1302?>
<p class="b1numlista" id="o6520"><a id="Case108-2" href="#Case0108-2">2</a>.&#160;<a id="p8540" />When diagnosing this entity using computerized tomography angiography (CTA), what specifically can obscure the disease or its extent?<a id="l1640" /></p><?mpslid S1303?>
<p class="b1numlist1a" id="o6525">A.&#160;<a id="p8545" />Arrhythmia</p><?mpslid E1303?><?mpslid S1304?>
<p class="b1numlist1a" id="o6530">B.&#160;<a id="p8550" />Adjacent soft tissue</p><?mpslid E1304?><?mpslid S1305?>
<p class="b1numlist1a" id="o6535">C.&#160;<a id="p8555" />Calcification</p><?mpslid E1305?><?mpslid S1306?>
<p class="b1numlist1a" id="o6540">D.&#160;<a id="p8560" />Breathing artifact</p><?mpslid E1306?><?mpslid E1302?><?mpslid S1307?>
<p class="b1numlista" id="o6545"><a id="Case108-3" href="#Case0108-3">3</a>.&#160;<a id="p8565" />Which of the following is the main reason why endovascular or surgical treatments have a poorer response in patients with diabetic peripheral arterial disease?<a id="l1645" /></p><?mpslid S1308?>
<p class="b1numlist1a" id="o6550">A.&#160;<a id="p8570" />Worse inflow disease</p><?mpslid E1308?><?mpslid S1309?>
<p class="b1numlist1a" id="o6555">B.&#160;<a id="p8575" />Worse outflow disease</p><?mpslid E1309?><?mpslid S1310?>
<p class="b1numlist1a" id="o6560">C.&#160;<a id="p8580" />Poor endovascular tools</p><?mpslid E1310?><?mpslid S1311?>
<p class="b1numlist1a" id="o6565">D.&#160;<a id="p8585" />Microvascular disease</p><?mpslid E1311?><?mpslid E1307?><?mpslid S1312?>
<p class="b1numlista" id="o6570"><a id="Case108-4" href="#Case0108-4">4</a>.&#160;<a id="p8590" />In which of the following patients would pedal access be appropriately employed for revascularization?<a id="l1650" /></p><?mpslid S1313?>
<p class="b1numlist1a" id="o6575">A.&#160;<a id="p8595" />A 46-year-old female claudicant with short segment superficial femoral artery disease, ankle brachial index (ABI) 0.74</p><?mpslid E1313?><?mpslid S1314?>
<p class="b1numlist1a" id="o6580">B.&#160;<a id="p8600" />A 54-year-old diabetic male with nonhealing great toe ulcer, ABI 0.3</p><?mpslid E1314?><?mpslid S1315?>
<p class="b1numlist1a" id="o6585">C.&#160;<a id="p8605" />A 72-year-old male claudicant with popliteal artery disease, ABI 0.6</p><?mpslid E1315?><?mpslid S1316?>
<p class="b1numlist1a" id="o6590">D.&#160;<a id="p8610" />All of the above</p><?mpslid E1316?><?mpslid E1312?>
</div>
<p id="p8615" class="b1text">
<a epub:type="noteref" href="#fn0285" id="Cfn0285">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0285">
<a href="#Cfn0285"><sup>*</sup></a><a id="np0285" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0545tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P220" epub:type="pagebreak" title="220" />
<div class="boxg1" id="b0555">
<p class="b1title">Answers</p>
<p class="b1subt">Case 108</p>
<section><a id="s2285" />
<p class="b11hd" id="st1975">Diabetes-Related Tibial Atherosclerosis</p>
<a id="p8620" />
<a id="l1655" />
<div><?mpslid S1317?>
<p class="b1numlista" id="o6595"><a id="Case0108-1" href="#Case108-1">1</a>.&#160;<a id="p8625" /><strong>A.</strong> The popliteal artery generally bifurcates into the anterior tibial artery and the tibioperoneal trunk. The tibioperoneal trunk then gives rise to the peroneal artery and the posterior tibial artery. Acute lower extremity arterial emboli are exceedingly rare. The given images show the arterial anatomy, and so the diagnosis of deep venous thrombosis cannot be made. The images also demonstrate the extensive tibial artery calcifications seen on a spot radiograph during an intervention.</p><?mpslid E1317?><?mpslid S1318?>
<p class="b1numlista" id="o6600"><a id="Case0108-2" href="#Case108-2">2</a>.&#160;<a id="p8630" /><strong>C.</strong> As seen in our case, calcifications can mimic endoluminal contrast, especially on three-dimensional reconstructed images. As such, the images may appear to show good flow even in the regions that are heavily calcified and occluded. Angiography as such remains the gold standard for evaluation.</p><?mpslid E1318?><?mpslid S1319?>
<p class="b1numlista" id="o6605"><a id="Case0108-3" href="#Case108-3">3</a>.&#160;<a id="p8635" /><strong>D.</strong> Microvascular disease in diabetic patients is a complex process that includes autonomic nervous dysfunction, impaired inflammatory response, and impaired oxygen diffusion among other issues, all of which result in poor wound healing. These patients commonly have adequate inflow and outflow vessels and usually tibial disease.</p><?mpslid E1319?><?mpslid S1320?>
<p class="b1numlista" id="o6610"><a id="Case0108-4" href="#Case108-4">4</a>.&#160;<a id="p8640" /><strong>B.</strong> Pedal access, although a very helpful access route, is usually reserved for use in patients with critical limb ischemia. It is commonly considered a salvage technique, as complications in a single tibial vessel could be devastating in a claudicant. However, many interventionalists are increasing their use and experience with pedal access and use it more frequently as sole access for infrapopliteal interventions.</p><?mpslid E1320?>
</div>
<section><a id="s2290" />
<p class="b12hd" id="st1980">Comment</p>
<section><a id="s2295" />
<p class="b13hd" id="st1985">Main Teaching Point</p>
<p id="p8645" class="b1textfl">Although smoking, hypertension, and hyperlipidemia also promote atherosclerosis, a particular pattern of arterial involvement is often seen in patients with diabetes mellitus. The primary feature of this pattern is multifocal severe stenoses and/or occlusions of the distal popliteal artery, tibioperoneal trunk, and the proximal segments of the anterior tibial, posterior tibial, and peroneal arteries. This typical pattern of disease often occurs in the presence of normal or near-normal iliac and femoral arteries although diabetic patients are certainly prone to atherosclerotic lesions in the more proximal arteries. An interesting finding also seen in these patients is peroneal sparing. Many of these patients have CTA (if renal function allows), magnetic resonance angiogram, or angiography for evaluation of anatomy and potential treatment planning (<a href="chp004_a.xhtml#f2105">Figures S108-1</a> through <a href="chp004_a.xhtml#f2120">S108-4</a>).</p>
</section>
<section><a id="s2300" />
<p class="b13hd" id="st1990">Disease Progression</p>
<p id="p8650" class="b1textfl">The clinical manifestations of diabetic arteriopathy are often more severe than the angiogram might indicate, because of the presence of microvascular disease not appreciated on angiography. Because patients with diabetic neuropathy are prone to pedal trauma, the combination of arterial insufficiency and trauma leads to frequent ulceration with difficulty in healing.</p>
</section>
<section><a id="s2305" />
<p class="b13hd" id="st1995">Treatment Methods</p>
<p id="p8655" class="b1textfl">Surgical arterial revascularization is commonly performed to help with ulcer healing in these patients. However, skilled interventionalists have had increasing success in treating these patients, especially with advanced techniques such as pedal access and subintimal arterial flossing with antegrade-retrograde intervention (<a href="chp004_a.xhtml#f2125">Figures S108-5</a> and <a href="chp004_a.xhtml#f2130">S108-6</a>). Unfortunately, limb amputation owing to vascular insufficiency is a fairly common event in this patient subset.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0285" />
<h3 class="ref2hd" id="st2000">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0895">1. Conte MS. Diabetic revascularization: endovascular versus open bypass&#8212;do we have the answer? <em>Semin Vasc Surg</em>. 2012;25:108&#8211;114.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0900">2. Gibbons GW, Shaw PM. Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient. <em>Semin Vasc Surg</em>. 2012;25:89&#8211;92.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0905">3. Pomposelli F. Arterial imaging in patients with lower extremity ischemia and diabetes mellitus. <em>J Vasc Surg</em>. 2010;52:81S&#8211;91S.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0910">4. Sabri SS, Hendricks N, Stone J, et al. Retrograde pedal access technique for revascularization of infrainguinal arterial occlusive disease. <em>J Vasc Interv Radiol</em>. 2015;26:29&#8211;38.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0235" />
<h3 class="ref2hd" id="st2005">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0915">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 347&#8211;351.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0285" />
<span id="P221" epub:type="pagebreak" title="221" />
<h2 class="h1hd" id="sc0285tit">Case 109</h2>
<a id="p8660" />
<div class="boxg1" id="b0560"><a id="p8665" />
<div class="pageavoid" id="f0560"><figure class="fig"><img src="../images/F000027b02-111-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 109-1</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0565"><figure class="fig"><img src="../images/F000027b02-112-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 109-2</span> <span class="figcredit">Courtesy of Dr. Lucia Flors Blasco.</span>
</figcaption>
</figure>
</div>
<section><a id="s2310" /><section><a id="s2315" /><section><a id="s2320" /><section><a id="s2325" />
<p class="b14hd" id="st2010">History</p>
<p id="p8670" class="b1textfl">A 28-year-old male with chronic low back pain.<a id="l1660" /></p>
<div><?mpslid S1321?>
<p class="b1numlista" id="o6615"><a id="Case109-1" href="#Case0109-1">1</a>.&#160;<a id="p8675" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1665" /></p><?mpslid S1322?>
<p class="b1numlist1a" id="o6620">A.&#160;<a id="p8680" />Duplicated inferior vena cava (IVC)</p><?mpslid E1322?><?mpslid S1323?>
<p class="b1numlist1a" id="o6625">B.&#160;<a id="p8685" />Left-sided IVC</p><?mpslid E1323?><?mpslid S1324?>
<p class="b1numlist1a" id="o6630">C.&#160;<a id="p8690" />Interruption of the intrahepatic IVC</p><?mpslid E1324?><?mpslid S1325?>
<p class="b1numlist1a" id="o6635">D.&#160;<a id="p8695" />Chronic IVC occlusion</p><?mpslid E1325?><?mpslid E1321?><?mpslid S1326?>
<p class="b1numlista" id="o6640"><a id="Case109-2" href="#Case0109-2">2</a>.&#160;<a id="p8700" />Which of the following imaging findings most likely indicates chronicity?<a id="l1670" /></p><?mpslid S1327?>
<p class="b1numlist1a" id="o6645">A.&#160;<a id="p8705" />Extension of the thrombosis from the iliofemoral veins</p><?mpslid E1327?><?mpslid S1328?>
<p class="b1numlist1a" id="o6650">B.&#160;<a id="p8710" />Prominent retroperitoneal collaterals</p><?mpslid E1328?><?mpslid S1329?>
<p class="b1numlist1a" id="o6655">C.&#160;<a id="p8715" />Enlargement of the IVC</p><?mpslid E1329?><?mpslid S1330?>
<p class="b1numlist1a" id="o6660">D.&#160;<a id="p8720" />Presence of pulmonary embolism</p><?mpslid E1330?><?mpslid E1326?><?mpslid S1331?>
<p class="b1numlista" id="o6665"><a id="Case109-3" href="#Case0109-3">3</a>.&#160;<a id="p8725" />Asymptomatic patients with chronic IVC occlusion are typically treated with:<a id="l1675" /></p><?mpslid S1332?>
<p class="b1numlist1a" id="o6670">A.&#160;<a id="p8730" />IVC stent</p><?mpslid E1332?><?mpslid S1333?>
<p class="b1numlist1a" id="o6675">B.&#160;<a id="p8735" />Anticoagulation</p><?mpslid E1333?><?mpslid S1334?>
<p class="b1numlist1a" id="o6680">C.&#160;<a id="p8740" />Lower-extremity compression</p><?mpslid E1334?><?mpslid S1335?>
<p class="b1numlist1a" id="o6685">D.&#160;<a id="p8745" />Anticoagulation and lower-extremity compression stockings</p><?mpslid E1335?><?mpslid E1331?><?mpslid S1336?>
<p class="b1numlista" id="o6690"><a id="Case109-4" href="#Case0109-4">4</a>.&#160;<a id="p8750" />Which of the following is the most appropriate endovascular therapy in patients with chronic IVC occlusion and severe symtpoms?<a id="l1680" /></p><?mpslid S1337?>
<p class="b1numlist1a" id="o6695">A.&#160;<a id="p8755" />Medical management</p><?mpslid E1337?><?mpslid S1338?>
<p class="b1numlist1a" id="o6700">B.&#160;<a id="p8760" />Graded compression stockings</p><?mpslid E1338?><?mpslid S1339?>
<p class="b1numlist1a" id="o6705">C.&#160;<a id="p8765" />Percutaneous balloon angioplasty alone</p><?mpslid E1339?><?mpslid S1340?>
<p class="b1numlist1a" id="o6710">D.&#160;<a id="p8770" />Recanalization and stenting</p><?mpslid E1340?><?mpslid E1336?>
</div>
<p id="p8775" class="b1text">
<a epub:type="noteref" href="#fn0290" id="Cfn0290">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0290">
<a href="#Cfn0290"><sup>*</sup></a><a id="np0290" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0550tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P222" epub:type="pagebreak" title="222" />
<div class="boxg1" id="b0565">
<p class="b1title">Answers</p>
<p class="b1subt">Case 109</p>
<section><a id="s2330" />
<p class="b11hd" id="st2015">Chronic IVC Occlusion</p>
<a id="p8780" />
<a id="l1685" />
<div><?mpslid S1341?>
<p class="b1numlista" id="o6715"><a id="Case0109-1" href="#Case109-1">1</a>.&#160;<a id="p8785" /><strong>D.</strong> Contrast-enhanced magnetic resonance images show occlusion of the juxtarenal and infrarenal IVC with extensive retroperitoneal collaterals. The intrahepatic IVC appears patent. No left-sided IVC is seen.</p><?mpslid E1341?><?mpslid S1342?>
<p class="b1numlista" id="o6720"><a id="Case0109-2" href="#Case109-2">2</a>.&#160;<a id="p8790" /><strong>B.</strong> The visualization of a prominent collateral network usually indicates long-term occlusion.</p><?mpslid E1342?><?mpslid S1343?>
<p class="b1numlista" id="o6725"><a id="Case0109-3" href="#Case109-3">3</a>.&#160;<a id="p8795" /><strong>D.</strong> Asymptomatic patients with chronic IVC occlusion are typically treated with anticoagulation and lower-extremity compression stockings.</p><?mpslid E1343?><?mpslid S1344?>
<p class="b1numlista" id="o6730"><a id="Case0109-4" href="#Case109-4">4</a>.&#160;<a id="p8800" /><strong>D.</strong> In carefully selected patients with severe postthrombotic syndrome, endovascular therapy may be attempted, which consists of recanalization and stenting to re-establish flow.</p><?mpslid E1344?>
</div>
<section><a id="s2335" />
<p class="b12hd" id="st2020">Comment</p>
<section><a id="s2340" />
<p class="b13hd" id="st2025">Pathophysiology</p>
<p id="p8805" class="b1textfl">The images demonstrate occlusion of the IVC with reconstitution of the intrahepatic segment and extensive collaterals from the lumbar venous plexus and azygos and hemiazygos system (<a href="chp004_a.xhtml#f2135">Figures S109-1</a> through <a href="chp004_a.xhtml#f2145">S109-3</a>). The visualization of prominent collateral network indicates long-standing IVC occlusion. Occlusion of the IVC can be caused by extension of iliofemoral deep vein thrombosis, IVC filters, and abdominal masses. Congenital absence of infrarenal IVC with preservation of the suprarenal segment is extremely rare and it is thought to represent the sequela from intrauterine or perinatal thrombosis of the IVC rather that a truly congenital anomaly.</p>
</section>
<section><a id="s2345" />
<p class="b13hd" id="st2030">Patient Management</p>
<p id="p8810" class="b1textfl">Patients with chronic IVC occlusion are typically treated with anticoagulation and lower-extremity compression stockings. Although this management is generally sufficient to prevent pulmonary embolism in all but a few cases, these patients tend to experience severe long-term postthrombotic syndrome which symptoms include chronic leg pain, swelling, redness, and ulcers. For this reason, in carefully selected patients with severe symptoms, endovascular therapy may be attempted. Endovascular therapy consists of recanalization and stenting with or without thrombolysis, as needed.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0290" />
<h3 class="ref2hd" id="st2035">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0920">1. Bjarnason H. Tips and tricks for stenting the inferior vena cava. <em>Semin Vasc Surg</em>. 2013;26(1):29&#8211;34.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0925">2. Kandpal H, Sharma R, Gamangatti S, Srivastava DN, Vashisht S. Imaging the inferior vena cava: a road less traveled. <em>RadioGraphics</em>. 2008;28:669&#8211;689.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0930">3. Razavi MK, Hansch EC, Kee ST, et al. Chronically occluded inferior venae cavae: endovascular treatment. <em>Radiology</em>. 2000;214:133&#8211;138.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0240" />
<h3 class="ref2hd" id="st2040">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0935">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 293&#8211;296.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0290" />
<span id="P223" epub:type="pagebreak" title="223" />
<h2 class="h1hd" id="sc0290tit">Case 110</h2>
<a id="p8815" />
<div class="boxg1" id="b0570"><a id="p8820" />
<div class="pageavoid" id="f0570"><figure class="fig"><img src="../images/F000027b02-113-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 110-1</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0575"><figure class="fig"><img src="../images/F000027b02-114-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 110-2</span> <span class="figcredit">Courtesy of Dr. Minhaj S. Khaja.</span>
</figcaption>
</figure>
</div>
<section><a id="s2350" /><section><a id="s2355" /><section><a id="s2360" /><section><a id="s2365" />
<p class="b14hd" id="st2045">History</p>
<p id="p8825" class="b1textfl">A 45-year-old male with cirrhosis and portal hypertension status post transjugular intrahepatic portosystemic shunt (TIPS) and balloon-retrograde transvenous obliteration presents with persistently elevated portal pressures and ascites.<a id="l1690" /></p>
<div><?mpslid S1345?>
<p class="b1numlista" id="o6735"><a id="Case110-1" href="#Case0110-1">1</a>.&#160;<a id="p8830" />Which of the following would be included in the differential diagnosis for the imaging findings presented? (Choose all that apply.)<a id="l1695" /></p><?mpslid S1346?>
<p class="b1numlist1a" id="o6740">A.&#160;<a id="p8835" />Patent TIPS</p><?mpslid E1346?><?mpslid S1347?>
<p class="b1numlist1a" id="o6745">B.&#160;<a id="p8840" />Splenomegaly</p><?mpslid E1347?><?mpslid S1348?>
<p class="b1numlist1a" id="o6750">C.&#160;<a id="p8845" />Ascites</p><?mpslid E1348?><?mpslid S1349?>
<p class="b1numlist1a" id="o6755">D.&#160;<a id="p8850" />Hepatocellular carcinoma (HCC)</p><?mpslid E1349?><?mpslid E1345?><?mpslid S1350?>
<p class="b1numlista" id="o6760"><a id="Case110-2" href="#Case0110-2">2</a>.&#160;<a id="p8855" />Which of the following is an indication for partial splenic embolization (PSE)?<a id="l1700" /></p><?mpslid S1351?>
<p class="b1numlist1a" id="o6765">A.&#160;<a id="p8860" />Bleeding gastric varices in a cirrhotic patient with an in-stent TIPS stenosis</p><?mpslid E1351?><?mpslid S1352?>
<p class="b1numlist1a" id="o6770">B.&#160;<a id="p8865" />Bleeding gastric varices in a cirrhotic patient with encephalopathy</p><?mpslid E1352?><?mpslid S1353?>
<p class="b1numlist1a" id="o6775">C.&#160;<a id="p8870" />Hepatogenic ascites in a patient with cirrhosis without encephalopathy</p><?mpslid E1353?><?mpslid S1354?>
<p class="b1numlist1a" id="o6780">D.&#160;<a id="p8875" />Hepatogenic ascites in a patient with a splenic to liver volume ratio of 0.2</p><?mpslid E1354?><?mpslid E1350?><?mpslid S1355?>
<p class="b1numlista" id="o6785"><a id="Case110-3" href="#Case0110-3">3</a>.&#160;<a id="p8880" />Which of the following is true regarding PSE in the setting of portal hypertension?<a id="l1705" /></p><?mpslid S1356?>
<p class="b1numlist1a" id="o6790">A.&#160;<a id="p8885" />The success of PSE for treating bleeding esophageal varices is a direct result of the reduction of the portosystemic pressure gradient.</p><?mpslid E1356?><?mpslid S1357?>
<p class="b1numlist1a" id="o6795">B.&#160;<a id="p8890" />It can effectively improve leukopenia.</p><?mpslid E1357?><?mpslid S1358?>
<p class="b1numlist1a" id="o6800">C.&#160;<a id="p8895" />It can exacerbate thrombocytopenia.</p><?mpslid E1358?><?mpslid S1359?>
<p class="b1numlist1a" id="o6805">D.&#160;<a id="p8900" />It cannot be used in the setting of sinistral portal hypertension.</p><?mpslid E1359?><?mpslid E1355?><?mpslid S1360?>
<p class="b1numlista" id="o6810"><a id="Case110-4" href="#Case0110-4">4</a>.&#160;<a id="p8905" />Which of the following is a relative contraindication to PSE?<a id="l1710" /></p><?mpslid S1361?>
<p class="b1numlist1a" id="o6815">A.&#160;<a id="p8910" />Bleeding esophageal varices in cirrhotic patients</p><?mpslid E1361?><?mpslid S1362?>
<p class="b1numlist1a" id="o6820">B.&#160;<a id="p8915" />Hepatopedal flow in the portal vein</p><?mpslid E1362?><?mpslid S1363?>
<p class="b1numlist1a" id="o6825">C.&#160;<a id="p8920" />Hepatofugal flow in the portal vein</p><?mpslid E1363?><?mpslid S1364?>
<p class="b1numlist1a" id="o6830">D.&#160;<a id="p8925" />Thrombosis of the superior mesenteric vein</p><?mpslid E1364?><?mpslid E1360?>
</div>
<p id="p8930" class="b1text">
<a epub:type="noteref" href="#fn0295" id="Cfn0295">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0295">
<a href="#Cfn0295"><sup>*</sup></a><a id="np0295" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0555tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P224" epub:type="pagebreak" title="224" />
<div class="boxg1" id="b0575">
<p class="b1title">Answers</p>
<p class="b1subt">Case 110</p>
<section><a id="s2370" />
<p class="b11hd" id="st2050">PSE in the Management of Portal Hypertension</p>
<a id="p8935" />
<a id="l1715" />
<div><?mpslid S1365?>
<p class="b1numlista" id="o6835"><a id="Case0110-1" href="#Case110-1">1</a>.&#160;<a id="p8940" /><strong>A, B, and C.</strong> The images demonstrate a patent TIPS in a patient with splenomegaly and ascites. No evidence of HCC is seen on the provided images.</p><?mpslid E1365?><?mpslid S1366?>
<p class="b1numlista" id="o6840"><a id="Case0110-2" href="#Case110-2">2</a>.&#160;<a id="p8945" /><strong>B.</strong> PSE can be employed for the treatment of various sequela of portal hypertension, such as gastric varices and hepatogenic ascites when TIPS is contraindicated and the spleen to liver volume ratio is 0.5 or greater. As such, the cirrhotic patient with bleeding esophageal varices in the setting of encephalopathy would be the best candidate. Additionally, PSE can be performed in patients who have had a TIPS with persistent splenomegaly and portal hypertension.</p><?mpslid E1366?><?mpslid S1367?>
<p class="b1numlista" id="o6845"><a id="Case0110-3" href="#Case110-3">3</a>.&#160;<a id="p8950" /><strong>B.</strong> PSE can effectively improve leukopenia by increasing the life-cycle of white blood cells (WBCs). PSE can also decrease sequestration and improve thrombocytopenia caused by hypersplenism. The mechanism by which PSE is thought to treat varices is by altering flow within the varices, not by directly reducing portal pressures. Patients with sinistral portal hypertension may benefit more from PSE over TIPS.</p><?mpslid E1367?><?mpslid S1368?>
<p class="b1numlista" id="o6850"><a id="Case0110-4" href="#Case110-4">4</a>.&#160;<a id="p8955" /><strong>C.</strong> Hepatofugal flow in the portal vein is considered a contraindication for PSE due to an increased risk of portal venous thrombosis.</p><?mpslid E1368?>
</div>
<section><a id="s2375" />
<p class="b12hd" id="st2055">Comment</p>
<section><a id="s2380" />
<p class="b13hd" id="st2060">Clinical Presentation</p>
<p id="p8960" class="b1textfl">Clinically significant portal hypertension can manifest in many ways. The most common presentations include, but are not limited to, variceal hemorrhage, hepatogenic ascites, hydrothorax, and hypersplenism that can subsequently lead to significant anemia and thrombocytopenia. While TIPS placement is considered the treatment of choice for reducing portal pressures when medical therapy fails to control symptoms of portal hypertension, it is not indicated and successful as sole therapy for all patients. For example, patients with advanced liver dysfunction, encephalopathy, and those with portal vein thrombosis should not undergo a TIPS procedure. Further, if the underlying cause of variceal bleeding is secondary to sinistral portal hypertension (isolated splenic vein thrombosis, which usually occurs as a complication of pancreatitis), TIPS should not be performed as PSE artery or splenectomy may successfully treat this source of variceal bleeding.</p>
</section>
<section><a id="s2385" />
<p class="b13hd" id="st2065">Indication</p>
<p id="p8965" class="b1textfl">The goal of PSE is to diminish inflow of blood into the portal vein that, in theory, would secondarily reduce the portal pressure. However, the changes in variceal flow, rather than changes in portal pressure, have been found to be more predictive of favorable outcomes and more likely account for the success of PSE in the setting of bleeding varices. PSE has also proven to be an effective treatment for hyperslenism-induced thrombocytopenia by reducing the size of the spleen and subsequently decreasing platelet sequestration. PSE can increase WBC counts in this patient population by increasing the overall WBC survival time. Additionally, recent studies have found that PSE has been helpful in treating patients with persistent ascites who have a widely patent TIPS, essentially splenomegaly with hyperdynamic portal hypertension (<a href="chp004_a.xhtml#f2150">Figures S110-1</a> through <a href="chp004_a.xhtml#f2175">S110-6</a>).</p>
</section>
<section><a id="s2390" />
<p class="b13hd" id="st2070">Imaging Evaluation</p>
<p id="p8970" class="b1textfl">Patients with a spleen-to-liver computed tomography (CT) volume ratio above 0.5 typically demonstrate a 20% decrease in portal pressures or more. Therefore a spleen-to-liver CT volume ratio above 0.5 is used as one inclusion criterion. Hepatofugal flow in the portal vein seen on Doppler ultrasound is considered a contraindication for PSE due to an increased risk of portal venous thrombosis.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0295" />
<h3 class="ref2hd" id="st2075">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0940">1. Kirby JM, Cho KJ, Midia M. Image-guided intervention in management of complications of portal hypertension: more than TIPS for success. <em>Radiographics</em>. 2013;33:1473&#8211;1496.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0945">2. Quintini C, D&#8217;Amico G, Brown C, et al. Splenic artery embolization for the treatment of refractory ascites after liver transplantation. <em>Liver Transpl</em>. 2011;17:668&#8211;673.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0950">3. Smith M, Ray CE. Splenic artery embolization as an adjunctive procedure for portal hypertension. <em>Semin Intervent Rad</em>. 2012;29:135&#8211;139.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr9640" />
<h3 class="ref2hd" id="st9640">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb9810">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 326.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0295" />
<span id="P225" epub:type="pagebreak" title="225" />
<h2 class="h1hd" id="sc0295tit">Case 111</h2>
<a id="p8975" />
<div class="boxg1" id="b0580"><a id="p8980" />
<div class="pageavoid" id="f0580"><figure class="fig"><img src="../images/F000027b02-115-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 111-1</span> <span class="figcredit">Courtesy of Dr. Daniel Brown.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0585"><figure class="fig"><img src="../images/F000027b02-116-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 111-2</span> <span class="figcredit">Courtesy of Dr. Daniel Brown.</span>
</figcaption>
</figure>
</div>
<section><a id="s2395" /><section><a id="s2400" /><section><a id="s2405" /><section><a id="s2410" />
<p class="b14hd" id="st2080">History</p>
<p id="p8985" class="b1textfl">A 48-year-old female taking oral contraceptives presents with vague abdominal pain and ascites.<a id="l1720" /></p>
<div><?mpslid S1369?>
<p class="b1numlista" id="o6855"><a id="Case111-1" href="#Case0111-1">1</a>.&#160;<a id="p8990" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1725" /></p><?mpslid S1370?>
<p class="b1numlist1a" id="o6860">A.&#160;<a id="p8995" />Primary sclerosing cholangitis</p><?mpslid E1370?><?mpslid S1371?>
<p class="b1numlist1a" id="o6865">B.&#160;<a id="p9000" />Budd-Chiari syndrome (BCS)</p><?mpslid E1371?><?mpslid S1372?>
<p class="b1numlist1a" id="o6870">C.&#160;<a id="p9005" />Cavernous transformation of the portal vein</p><?mpslid E1372?><?mpslid S1373?>
<p class="b1numlist1a" id="o6875">D.&#160;<a id="p9010" />Cirrhosis</p><?mpslid E1373?><?mpslid E1369?><?mpslid S1374?>
<p class="b1numlista" id="o6880"><a id="Case111-2" href="#Case0111-2">2</a>.&#160;<a id="p9015" />Which of the following imaging tests is the gold standard for diagnosis of this condition?<a id="l1730" /></p><?mpslid S1375?>
<p class="b1numlist1a" id="o6885">A.&#160;<a id="p9020" />Computed tomography (CT)</p><?mpslid E1375?><?mpslid S1376?>
<p class="b1numlist1a" id="o6890">B.&#160;<a id="p9025" />Ultrasound</p><?mpslid E1376?><?mpslid S1377?>
<p class="b1numlist1a" id="o6895">C.&#160;<a id="p9030" />Magnetic resonance imaging (MRI)</p><?mpslid E1377?><?mpslid S1378?>
<p class="b1numlist1a" id="o6900">D.&#160;<a id="p9035" />Hepatic venography</p><?mpslid E1378?><?mpslid E1374?><?mpslid S1379?>
<p class="b1numlista" id="o6905"><a id="Case111-3" href="#Case0111-3">3</a>.&#160;<a id="p9040" />Which of the following endovascular procedures is used in the management of this condition? (Select all that apply.)<a id="l1735" /></p><?mpslid S1380?>
<p class="b1numlist1a" id="o6910">A.&#160;<a id="p9045" />Balloon angioplasty and stenting</p><?mpslid E1380?><?mpslid S1381?>
<p class="b1numlist1a" id="o6915">B.&#160;<a id="p9050" />Catheter-directed thrombolysis</p><?mpslid E1381?><?mpslid S1382?>
<p class="b1numlist1a" id="o6920">C.&#160;<a id="p9055" />Transjugular intrahepatic portosystemic shunt (TIPS)</p><?mpslid E1382?><?mpslid S1383?>
<p class="b1numlist1a" id="o6925">D.&#160;<a id="p9060" />Inferior vena cava (IVC) filter placement</p><?mpslid E1383?><?mpslid E1379?><?mpslid S1384?>
<p class="b1numlista" id="o6930"><a id="Case111-4" href="#Case0111-4">4</a>.&#160;<a id="p9065" />With which of the following disease processes is this entity associated?<a id="l1740" /></p><?mpslid S1385?>
<p class="b1numlist1a" id="o6935">A.&#160;<a id="p9070" />Hypertension</p><?mpslid E1385?><?mpslid S1386?>
<p class="b1numlist1a" id="o6940">B.&#160;<a id="p9075" />Congestive heart failure</p><?mpslid E1386?><?mpslid S1387?>
<p class="b1numlist1a" id="o6945">C.&#160;<a id="p9080" />Hematologic disorders including polycythemia vera</p><?mpslid E1387?><?mpslid S1388?>
<p class="b1numlist1a" id="o6950">D.&#160;<a id="p9085" />Hepatic metastases</p><?mpslid E1388?><?mpslid E1384?>
</div>
<p id="p9090" class="b1text">
<a epub:type="noteref" href="#fn0300" id="Cfn0300">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0300">
<a href="#Cfn0300"><sup>*</sup></a><a id="np0300" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0560tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P226" epub:type="pagebreak" title="226" />
<div class="boxg1" id="b0585">
<p class="b1title">Answers</p>
<p class="b1subt">Case 111</p>
<section><a id="s2415" />
<p class="b11hd" id="st2085">Budd-Chiari Syndrome</p>
<a id="p9095" />
<a id="l1745" />
<div><?mpslid S1389?>
<p class="b1numlista" id="o6955"><a id="Case0111-1" href="#Case111-1">1</a>.&#160;<a id="p9100" /><strong>B.</strong> BCS refers to a group of disorders characterized by hepatic venous outflow obstruction, with hepatic venography classically demonstrating a complex spider-web-like network of collateral veins draining directly into the IVC. Cavernous transformation of the portal vein occurs as a result of portal vein thrombosis with the formation of venous collateral channels.</p><?mpslid E1389?><?mpslid S1390?>
<p class="b1numlista" id="o6960"><a id="Case0111-2" href="#Case111-2">2</a>.&#160;<a id="p9105" /><strong>D.</strong> Hepatic venography allows for anatomic characterization of the venous outflow problem, hemodynamic information in the form of pressure measurements, histologic correlation via transjugular liver biopsy, and endovascular management.</p><?mpslid E1390?><?mpslid S1391?>
<p class="b1numlista" id="o6965"><a id="Case0111-3" href="#Case111-3">3</a>.&#160;<a id="p9110" /><strong>A, B, and C.</strong> Balloon angioplasty and stenting may effectively treat isolated hepatic vein or IVC stenoses or occlusions, catheter-directed thrombolysis may effectively treat IVC thrombosis, and TIPS may effectively decompress the obstructed hepatic venous system if isolated hepatic vein or IVC interventions fail.</p><?mpslid E1391?><?mpslid S1392?>
<p class="b1numlista" id="o6970"><a id="Case0111-4" href="#Case111-4">4</a>.&#160;<a id="p9115" /><strong>C.</strong> Approximately 75% of BCS patients have a hematologic disorder such as polycythemia vera or a thrombotic diathesis, such as pregnancy or inherited factor V Leiden mutation.</p><?mpslid E1392?>
</div>
<section><a id="s2420" />
<p class="b12hd" id="st2090">Comment</p>
<section><a id="s2425" />
<p class="b13hd" id="st2095">Clinical Presentation</p>
<p id="p9120" class="b1textfl">Patients with BCS present with severe ascites (85% to 90% of patients), hepatosplenomegaly, abdominal pain, jaundice, vomiting, and lower extremity edema. If untreated, BCS patients develop progressive portal hypertension with esophageal variceal bleeding, encephalopathy, hepatic failure, and death. BCS can be caused by tumor invasion of the IVC or hepatic veins, membranous suprahepatic IVC obstruction, right atrial tumors, and hematologic disorders and thrombotic diatheses including myeloproliferative disorders such as polycythemia vera, pregnancy, postpartum state, oral contraceptive use, paroxysmal nocturnal hemoglobinuria, venoocclusive disease (in patients who have received chemotherapy and radiation), and heritable conditions such as factor V Leiden mutation.</p>
</section>
<section><a id="s2430" />
<p class="b13hd" id="st2100">Imaging Interpretation</p>
<p id="p9125" class="b1textfl">CT and MRI findings in BCS include hepatomegaly, ascites, caudate lobe hypertrophy, inhomogeneous enhancement which is greater centrally, IVC compression, and nonvisualization of the hepatic veins. Duplex ultrasound can demonstrate hepatic vein flow to be absent, reversed, turbulent, or monophasic. Hepatic venography, the gold standard for diagnosis, can demonstrate webs, stenosis, or thrombus within the suprahepatic IVC or hepatic veins with abundant collaterals between the main hepatic veins (<a href="chp004_a.xhtml#f2180">Figures S111-1</a> through <a href="chp004_a.xhtml#f2190">S111-3</a>).</p>
</section>
<section><a id="s2435" />
<p class="b13hd" id="st2105">Endovascular Management</p>
<p id="p9130" class="b1textfl">Patients with BCS due to IVC or hepatic vein stenosis may be treated effectively with balloon angioplasty or stent placement (when stenosis recurs following angioplasty). Patients with IVC thrombosis may be treated with thrombolytic therapy. Patients with hepatic vein thrombosis have been successfully treated with TIPS, although this may be technically difficult to perform and the long-term results of this approaches are unknown (<a href="chp004_a.xhtml#f2195">Figure S111-4</a>). TIPS in these patients tend to be longer due to a hypertrophied caudate lobe and enlarged and congested liver parenchyma.</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0300" />
<h3 class="ref2hd" id="st2110">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0955">1. Brancatelli G, Vilgrain V, Federle MP, et al. Budd-Chiari syndrome: spectrum of imaging findings. <em>Am J Roentgenol</em>. 2007;188:W168&#8211;W176.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0960">2. Cura M, Haskal Z, Lopera J. Diagnostic and interventional radiology for Budd-Chiari syndrome. <em>Radiographics</em>. 2009;29:669&#8211;681.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0965">3. Ferral H, Behrens G, Lopera J. Budd-Chiari syndrome. <em>Am J Roentgenol</em>. 2012;199:737&#8211;745.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0970">4. Mancuso A, Fung K, Mela M, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. <em>J Hepatol</em>. 2003;38:751&#8211;754.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0245" />
<h3 class="ref2hd" id="st2115">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0975">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 326&#8211;327.</p>
</section>
</footer>
</section>
<div class="pagebreak" />
<section epub:type="subchapter"><a id="sc0300" />
<span id="P227" epub:type="pagebreak" title="227" />
<h2 class="h1hd" id="sc0300tit">Case 112</h2>
<a id="p9135" />
<div class="boxg1" id="b0590"><a id="p9140" />
<div class="pageavoid" id="f0590"><figure class="fig"><img src="../images/F000027b02-117-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 112-1</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<div class="pageavoid" id="f0595"><figure class="fig"><img src="../images/F000027b02-118-9781455776306.jpg" class="img" alt="image" /><br /><figcaption class="figleg"><span class="fignum">Figure 112-2</span> <span class="figcredit">Courtesy of Dr. Bill S. Majdalany.</span>
</figcaption>
</figure>
</div>
<section><a id="s2440" /><section><a id="s2445" /><section><a id="s2450" /><section><a id="s2455" />
<p class="b14hd" id="st2120">History</p>
<p id="p9145" class="b1textfl">A 56-year-old male with presents bleeding esophageal varices.<a id="l1750" /></p>
<div><?mpslid S1393?>
<p class="b1numlista" id="o6975"><a id="Case112-1" href="#Case0112-1">1</a>.&#160;<a id="p9150" />Which of the following is the most likely diagnosis for the imaging findings presented?<a id="l1755" /></p><?mpslid S1394?>
<p class="b1numlist1a" id="o6980">A.&#160;<a id="p9155" />Cavernous transformation of the portal vein</p><?mpslid E1394?><?mpslid S1395?>
<p class="b1numlist1a" id="o6985">B.&#160;<a id="p9160" />Esophageal varix after transjugular intrahepatic portosystemic shunt (TIPS) placement</p><?mpslid E1395?><?mpslid S1396?>
<p class="b1numlist1a" id="o6990">C.&#160;<a id="p9165" />Contrast extravasation secondary to iatrogenic dissection/rupture during TIPS</p><?mpslid E1396?><?mpslid S1397?>
<p class="b1numlist1a" id="o6995">D.&#160;<a id="p9170" />Hepatic arteriovenous malformation</p><?mpslid E1397?><?mpslid E1393?><?mpslid S1398?>
<p class="b1numlista" id="o7000"><a id="Case112-2" href="#Case0112-2">2</a>.&#160;<a id="p9175" />In the setting of residual varices with a patent TIPS and a portosystemic pressure gradient (PSG) less than 12&#160;mm&#160;Hg, what additional procedure may be performed as treatment of the varices?<a id="l1760" /></p><?mpslid S1399?>
<p class="b1numlist1a" id="o7005">A.&#160;<a id="p9180" />Additional stenting of the TIPS to further decrease the portosystemic gradient</p><?mpslid E1399?><?mpslid S1400?>
<p class="b1numlist1a" id="o7010">B.&#160;<a id="p9185" />Infusion of nonselective beta blockers</p><?mpslid E1400?><?mpslid S1401?>
<p class="b1numlist1a" id="o7015">C.&#160;<a id="p9190" />Embolization of the varices</p><?mpslid E1401?><?mpslid S1402?>
<p class="b1numlist1a" id="o7020">D.&#160;<a id="p9195" />Surgical creation of a portocaval shunt</p><?mpslid E1402?><?mpslid E1398?><?mpslid S1403?>
<p class="b1numlista" id="o7025"><a id="Case112-3" href="#Case0112-3">3</a>.&#160;<a id="p9200" />Which of the following are benefits of adjunctive embolotherapy of varices during TIPS?<a id="l1765" /></p><?mpslid S1404?>
<p class="b1numlist1a" id="o7030">A.&#160;<a id="p9205" />Decreased incidence of hepatic encephalopathy</p><?mpslid E1404?><?mpslid S1405?>
<p class="b1numlist1a" id="o7035">B.&#160;<a id="p9210" />Decreased incidence of variceal rebleeding</p><?mpslid E1405?><?mpslid S1406?>
<p class="b1numlist1a" id="o7040">C.&#160;<a id="p9215" />Decreased 6-month mortality</p><?mpslid E1406?><?mpslid S1407?>
<p class="b1numlist1a" id="o7045">D.&#160;<a id="p9220" />Decreased incidence of shunt malfunction or failure</p><?mpslid E1407?><?mpslid E1403?><?mpslid S1408?>
<p class="b1numlista" id="o7050"><a id="Case112-4" href="#Case0112-4">4</a>.&#160;<a id="p9225" />Which of the following statements is correct?<a id="l1770" /></p><?mpslid S1409?>
<p class="b1numlist1a" id="o7055">A.&#160;<a id="p9230" />Esophageal varices are more common than gastric varices and are associated with higher bleeding and mortality rates.</p><?mpslid E1409?><?mpslid S1410?>
<p class="b1numlist1a" id="o7060">B.&#160;<a id="p9235" />Gastric varices are more common than esophageal varices and are associated with higher bleeding and mortality rates.</p><?mpslid E1410?><?mpslid S1411?>
<p class="b1numlist1a" id="o7065">C.&#160;<a id="p9240" />Esophageal varices are less common than gastric varices and are associated with higher bleeding and mortality rates.</p><?mpslid E1411?><?mpslid S1412?>
<p class="b1numlist1a" id="o7070">D.&#160;<a id="p9245" />Gastric varices are less common than esophageal varices and are associated with higher bleeding and mortality rates.</p><?mpslid E1412?><?mpslid E1408?>
</div>
<p id="p9250" class="b1text">
<a epub:type="noteref" href="#fn0305" id="Cfn0305">*</a></p>
</section>
</section>
</section>
</section>
<footer>
<hr />
<p class="b1ftnote" epub:type="footnote" id="fn0305">
<a href="#Cfn0305"><sup>*</sup></a><a id="np0305" /><em>See Supplemental Figures section for additional figures and legends for this <a href="chp004_a.xhtml#sc0565tit">case</a></em>.</p>
</footer>
</div>
<div class="pagebreak" />
<div id="P228" epub:type="pagebreak" title="228" />
<div class="boxg1" id="b0595">
<p class="b1title">Answers</p>
<p class="b1subt">Case 112</p>
<section><a id="s2460" />
<p class="b11hd" id="st2125">Post-TIPS Variceal Embolization</p>
<a id="p9255" />
<a id="l1775" />
<div><?mpslid S1413?>
<p class="b1numlista" id="o7075"><a id="Case0112-1" href="#Case112-1">1</a>.&#160;<a id="p9260" /><strong>B.</strong> Images are most representative of an esophageal varix that may persist status post-TIPS and that correlate with high risk of subsequent hemorrhage and mortality.</p><?mpslid E1413?><?mpslid S1414?>
<p class="b1numlista" id="o7080"><a id="Case0112-2" href="#Case112-2">2</a>.&#160;<a id="p9265" /><strong>C.</strong> Embolization of the varices with metallic coils or sclerosing agents may be performed before or after TIPS as an adjunctive measure. Concurrent embolotherapy has been shown to decrease the rate of variceal rebleeding. Additional stenting of a TIPS with a PSG less than 12&#160;mm&#160;Hg will not affect the varices. Nonselective beta-blockers are a prophylactic treatment shown to slow variceal growth and are not a definitive treatment of existing varices or variceal hemorrhage. Surgical creation of a portosystemic shunt is an alternative to TIPS, not an adjunctive treatment.</p><?mpslid E1414?><?mpslid S1415?>
<p class="b1numlista" id="o7085"><a id="Case0112-3" href="#Case112-3">3</a>.&#160;<a id="p9270" /><strong>B.</strong> Recent studies have shown adjunctive variceal embolization to decrease rate of variceal rebleed and increase time between episodes of rebleeding. A meta-analysis found no significant difference between TIPS with or without adjunctive variceal embolization regarding shunt function, encephalopathy, or mortality.</p><?mpslid E1415?><?mpslid S1416?>
<p class="b1numlista" id="o7090"><a id="Case0112-4" href="#Case112-4">4</a>.&#160;<a id="p9275" /><strong>D.</strong> Gastric varices are less common than esophageal varices, found in approximately 20% of patients with portal hypertension, whereas approximately 30% to 60% of patients with portal hypertension are found to have esophageal varices. Gastric varices are associated with more bleeding and higher mortality rates.</p><?mpslid E1416?>
</div>
<section><a id="s2465" />
<p class="b12hd" id="st2130">Comment</p>
<section><a id="s2470" />
<p class="b13hd" id="st2135">Main Teaching Point</p>
<p id="p9280" class="b1textfl">The hemodynamic goal of TIPS is to achieve the optimal degree of reduction in the portosystemic gradient that will prevent variceal bleeding and ascites, but that will preserve hepatic perfusion (thereby preventing encephalopathy and liver failure). In most patients, reducing the portosystemic gradient to 8 to 12&#160;mm&#160;Hg produces this effect. Likewise, in most patients, portal venography performed immediately after TIPS demonstrates markedly reduced filling of gastroesophageal varices compared to the pre-TIPS venogram. In a minority of patients, however, persistent variceal filling is observed (<a href="chp004_a.xhtml#f2200">Figure S112-1</a>). Visualizing the varices after the successful placement of a widely-patent TIPS is subjective, and there are no clear objective criteria as to which visualized varices need to be embolized.</p>
</section>
<section><a id="s2475" />
<p class="b13hd" id="st2140">Main Teaching Point</p>
<p id="p9285" class="b1textfl">When persistent variceal filling is found post-TIPS, the presence of residual stenosis or thrombus within the TIPS tract or portal vein should first be sought and corrected by additional angioplasty. If variceal filling is still observed, or in select cases in which the patient is hemodynamically unstable due to variceal bleeding, the gastroesophageal varices can be selected from the portal venous system and percutaneously embolized using coils or sclerosant (<a href="chp004_a.xhtml#f2205">Figure S112-2</a>).</p>
</section>
</section>
</section>
</div>
<footer>
<section epub:type="bibliography"><a id="bi0305" />
<h3 class="ref2hd" id="st2145">References</h3>
<section>
<p class="reflist" epub:type="biblioentry footnote" id="bb0980">1. Chen S, Li X, Wei B, et al. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. <em>Radiology</em>. 2013;268:900&#8211;906.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0985">2. Qi X, Liu L, Bai M, et al. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis. <em>J Gastroenterol Hepatol</em>. 2014;29:688&#8211;696.</p>
<p class="reflist" epub:type="biblioentry footnote" id="bb0990">3. Tesdal K, Filser T, Weiss C, et al. Transjugular intrahepatic portosystemic shunts: adjunctive embolotherapy of gastroesophageal collateral vessels in the prevention of variceal rebleeding. <em>Radiology</em>. 2005;236:360&#8211;367.</p>
</section>
</section>
<section epub:type="bibliography"><a id="fr0250" />
<h3 class="ref2hd" id="st2150">Cross-reference</h3>
<p class="reflist" epub:type="biblioentry footnote" id="bb0995">1. <em>Vascular and Interventional Radiology: The Requisites</em>, 2nd ed, 315&#8211;325.</p>
</section>
</footer>
</section>
</section>
</body>
</html>